Chercheur(e)

Dr Gilles R. Dagenais

Cardiologie

U4762

gilles.dagenais@criucpq.ulaval.ca

Domaine de recherche

Essais cliniques randomisés, épidémiologie, maladie coronarienne, accidents vasculaires cérébraux, maladie artérielle périphérique, diabète, facteurs de risque cardiovasculaires, pharmacologie, pronostic, physiopathologie.

Description des travaux

Première mise en évidence d'un réservoir dynamique de triglycérides dans le muscle squelettique et subséquemment dans le myocarde chez l'humain.

Métabolisme myocardique lors de l'ischémie induite par cardiostimulation et exercice.

Impacts pronostiques de la tolérance à l'effort chez les patients avec une cardiopathie ischémique stable. Absence d'effets bénéfiques de la digitale sur la mortalité des patients avec insuffisance cardiaque (étude DIG) et du diltiazem chez les patients avec infarctus récent (MDPIT).

Évaluation des facteurs de risque cardiovasculaire dans la population de Québec; prévalence des facteurs de risque cardiovasculaire; impact pronostique de substrats métaboliques; importance de la durée du diabète sur les maladies cardiovasculaires; histoire naturelle de la maladie artérielle périphérique (projet cardiovasculaire de Québec, suivi 25 ans).

Effets bénéfiques des modulateurs de l'angiotensine sur le pronostic des patients avec un risque élevé, avec et sans diabète (HOPE, ONTARGET).

Absence d'effets bénéfiques cardiovasculaires de la vitamine E, de l'acide folique, des Oméga-3 et de l'insuline sur le pronostic des patients à risque élevé, avec ou sans diabète (HOPE, HOPE-TOO, ORIGIN).

Réduction de l'incidence du diabète chez les personnes à risque avec la rosiglitazone et l'insuline mais non le ramipril (DREAM, ORIGIN).

Réduction plus importante de l'angine de poitrine chez les diabétiques par pontages
aortocoronariens comparativement à l'angioplastie; pronostic similaire des patients coronariens, diabétiques stables, symptomatiques et asymptomatiques (BARI2-D).

Impact pronostique du traitement sur la tension artérielle élevée et une dyslipidémie légère (HOPE-3, TIPS-3).

Évaluation du rivaroxaban et de l'aspirine sur le pronostic cardiovasculaire des patients avec un risque élevé.

Étude PURE (suivi prévu 12 ans) portant sur les causes des causes des maladies cardiovasculaires, cancers, diabète, obésité et accidents chez 155 000 adultes dans 17 pays socio-économiquement différents; évaluations génétiques et environnementales sur ces différentes maladies; sous-études sur la consommation de sodium, les déficits cognitifs et AVC silencieux.

Prix et distinctions

2013: Prix de reconnaissance de l’IUCPQ
2013: Prix de reconnaissance de PHRI, Université McMaster
2009: Prix de reconnaissance CANNECTIN
2007: Prix de reconnaissance de l’Association des cardiologues du Québec
2003-2011: Membre du comité éditorial international de l’European Journal of Cardiovascular Prevention and Rehabilitation
2002: Prix IMS
2002: Prix de reconnaissance 2002 de la Société canadienne de cardiologie
2001: Prix d’excellence 2000 de la Fondation des maladies du coeur du Canada
2001: Professeur émérite, Université Laval
2000: Professeur émérite, Université de Montréal
1999-: Membre honoraire de la Société de cardiologie d’Argentine
1998: Prix Dr. Harold N. Segall de la Société canadienne de cardiologie
1997-2001: Membre du comité éditorial international. Cardiology in Review
1997 : Président de la 4e Conférence internationale de cardiologie préventive
1996-2000 : Vice-président de la Société InterAméricaine de Cardiologie
1996: Prix Coeur Or de la Fondation des maladies du Coeur du Québec
1996-: Membre de l’American clinical and climatological association
1996-: Membre honoraire de la Société canadienne de cardiologie nucléaire
1995 : Président de l’association des directeurs de départements de médecine du Canada
1994-99 : Éditeur associé, Journal Canadien de Cardiologie
1994: Prix Dupont Pharma, Dalhousie University
1992-94: Président de la Société canadienne de cardiologie
1991-99: Directeur du département de médecine, Université de Montréal
1990- Membre honoraire de la Société française de cardiologie
1988: Prix de la Conférence 1988 de la Société canadienne de cardiologie
1980-84: Gouverneur de la Province de Quebec, American College of Cardiology
1980-87: Directeur, Institut de cardiologie de Québec
1973-80 : Chef du service de cardiologie et directeur de la recherche, Institut de cardiologie de Québec
1973: Prix interuniversitaire Joseph C. Edwards (avec les Drs J. Rochon et P.J.Lupien)

Publications

185

Trier par année :

Cantin B, Lamarche B, Després JP, Dagenais GR. Does correction of the friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study.. Atherosclerosis 2002; 163(2):261-7.
Cantin B, Després JP, Lamarche B, Moorjani S, Lupien PJ, Bogaty P, Bergeron J, Dagenais GR. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). Am J Cardiol 2002; 89(6):662-6.
Pirro M, Mauriège P, Tchernof A, Cantin B, Dagenais GR, Després JP, Lamarche B. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.. Atherosclerosis 2002; 160(2):377-84.
Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.. Diabetes Care 2002; 25(11):1919-27.
Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J, Suhan P, Micks M, Probstfield J, Bernstein V, Yusuf S. Effect of long-term therapy with ramipril in high-risk women.. J Am Coll Cardiol 2002; 40(4):693-702.
Bogaty P, Dagenais GR, Poirier P, Boyer L, Auclair L, Pépin G, Jobin J, Arsenault M. Effect of atorvastatin on exercise-induced myocardial ischemia in patients with stable angina pectoris. Am J Cardiol 2003; 92(10):1192-5.
Dagenais GR, Auger P, Bogaty P, Gerstein H, Lonn E, Yi Q, Yusuf S,. Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity. Can J Cardiol 2003; 19(12):1387-91.
Bogaty P, Poirier P, Boyer L, Jobin J, Dagenais GR. What induces the warm-up ischemia/angina phenomenon: exercise or myocardial ischemia?. Circulation 2003; 107(14):1858-63.
Sniderman AD, St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.. Am J Cardiol 2003; 91(10):1173-7.
St-Pierre AC, Bergeron J, Pirro M, Cantin B, Dagenais GR, Després JP, Lamarche B,. Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study).. Am J Cardiol 2003; 91(5):555-8.
Lonn E, Mathew J, Pogue J, Johnstone D, Danisa K, Bosch J, Baird M, Dagenais G, Sleight P, Yusuf S,. Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients.. Eur J Cardiovasc Prev Rehabil 2003; 10(6):420-8.
Bogaty P, Brophy JM, Noel M, Boyer L, Simard S, Bertrand F, Dagenais GR. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled. Circulation 2004; 110(8):934-9.
Brophy JM, Dagenais G, McSherry F, Williford W, Yusuf S. Predicting mortality and hospitalizations in 6422 patients with congestive heart failure.. Am J Med 2004; 116(0):300-4.
Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais G, Sussex B, Steingart RM, Brown EJ, Lamas GA, Gordon D, Bernstein V, Pfeffer MA. Survival and ventricular enlargement trial. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infraction with left ventricular s. Am Heart J 2004; 148(2):356-64.
Mann JF, Loon EM, Yi Q, Gerstein HC, Hoogwerf BJ, Pogue J, Bosch J, Dagenais G, Yusuf S. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.. Kidney Int 2004; 65(4):1375-80.
Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, Yusuf S,. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.. Eur Heart J 2004; 25(1):17-24.
Teo KK, Mitchell LB, Pogue J, Bosch J, Dagenais G, Yusuf S,. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.. Circulation 2004; 110(11):1413-7.
St-Pierre AC, Cantin B, Dagenais GR, Mauriège P, Bernard PM, Després JP, Lamarche B. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.. Arterioscler Thromb Vasc Biol 2005; 25(3):553-9.
Dagenais GR. Can the Canadian Cardiovascular society grading scale of angina influence clinical management and predict outcomes?. Can J Cardiol 2004; 20(0):310.
St-Pierre A, Cantin B, Dagenais GR, Mauriège P, Després J-P, Lamarche B. The triglyceride/high density lipoprotein cholesterol ratio, the small dense low density lipoprotein phenotype and ischemic heart disease risk.. Metabolic Syndrome and Related Disorders 2004; 2(0):57-64.
Bogaty P, Brophy JM, Boyer L, Simard S, Joseph L, Bertrand F, Dagenais GR. Fluctuating inflammatory markers in patients with stable ischemic heart disease.. Arch Intern Med 2005; 165(2):221-6.
St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, Després JP, Lamarche B. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease.. CMAJ 2005; 172(10):1301-5.
St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.. Am J Cardiol 2006; 97(7):997-1001.
St-Pierre AC, Cantin B, Bergeron J, Pirro M, Dagenais GR, Després JP, Lamarche B. Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study.. Atherosclerosis 2005; 182(2):315-21.
Dagenais GR, Yi Q, Mann JFE, Bosch J, Pogue J, Yusuf S. Prognostic impact of body mass index and abdominal obesity in women and men with cardiovascular disease.. Am Heart J 2005; 149(0):54-60.
Mann JFE, Yi Q, Lonn EM, Dagenais GR, Probstfield J, Gerstein HC, Yusuf S. Serum potassium, cardiovascular risk, and effects of ramipril.. Clin Nephrol 2005; 63(0):181-7.
Dagenais GR, Yi Q, Lonn E, Sleight O, Ostergren J, Yusuf S. Impact of cigarette smoking in patients participating in a clinical trial. A substudy from The Heart Outcomes Prevention Evaluation (HOPE).. Eur J Cardiovasc Prev Rehabil 2005; 12(0):75-81.
Brisson C, Leblanc R, Bourbonnais R, Maunsell E, Dagenais GR, Vézina M, Masse B, Kroger E. Psychologic distress in postmyocardial infarction patients who have returned to work.. Psychosom Med 2005; 67(0):59-63.
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR (HOPE and HOPE-TOO study investigators). Effect of long-term Vitamin E supplementation on cardiovascular events and cancer. The HOPE study extension.. JAMA 2005; 293(0):1338-47.
Bosch J, Lonn E, Pogue J, Arnold M, Dagenais GR, Yusuf S (HOPE and HOPE-TOO study investigators). Long-term effects of Ramipril on cardiovascular events and on diabetes: Results of the HOPE study extension.. Circulation 2005; 112(0):1339-46.
St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B. The relationship between dysglycemia, cardiovascular and renal risk in diabetic and nondiabetic participants in the HOPE study: A prospective epidemiologic analysis.. Diabetologia 2005; 48(0):1749-55.
Noël M, Jobin J, Poirier P, Dagenais GR and Bogaty P. Different thresholds of myocardical ischemia in ramp and standard Bruce protocol exercise tests in patients with positive exercise stress tests and angiographically demonstrated coronary arterial narr. Am J Cardiol 2007; 99(7):921-4.
Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais G, Yusuf S, Lonn E. Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.. Eur Heart J 2007; 28(11):1382-8.
Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson, ONTARGET Investigators. Telmisartan, Ramipril or both in patients at high risk of vascular events.. N Engl J Med 2008; 358(15):1547-59.
Dagenais GR, Pogue J, Theo KK, Lonn EM, Yusuf S. Impact of Ramipril on the circadian periodicity of acute myocardial infarction.. Am J Cardiol 2006; 98(6):758-60.
DREAM Trial Investigators: Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais GR, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR. Effects of rosiglitazone on the incidence of diabetes in people with impaired glucose tolerance or impaired fasting glucose.. Lancet 2006; 368(0):1096-105.
Guimont JC, Brisson C, Dagenais GR, Milot A, Vézina M, Mâsse B, Moisan J, Laflamme N, Blanchette C. Effects of job strain on blood pressure: a prospective study of male and female white-collar workers.. Am J Public Health 2006; 96(8):1436-43.
Noël M, Jobin J, Marcoux A, Poirier P, Dagenais GR, Bogaty P. Can prolonged exercise-induced myocardial ischemia be innocuous?. Eur Heart J 2007; 28(13):1559-65.
Dagenais GR, Pogue J, Fox K, Smoons ML, Yusuf S. Angiotensin-converting enzyme inhibitors in patients with stable vascular disease without left ventricular systolic dysfunction or heart failure.. Lancet 2006; 368(9535):581-8.
DREAM Trial Investigators: Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR. Effect of ramipril on the incidence of diabetes.. N Engl J Med 2006; 355(15):1551-62.
Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E. The Prognostic Significance of Bundle Branch Block in High-Risk Chronic Stable Vascular Disease Patients: A Report from the HOPE Trial.. J Cardiovasc Electrophysiol 2009; 20(7):781-7.
Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S, DREAM Trial Investigators. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with rami. Diabetes Care 2008; 31(5):1007-14.
Salehian O, Healey J, Stambler B, Alnemer K, Almerri K, Grover J, Bata I, Mann J, Matthew J, Pogue J, Yusuf S, Dagenais G, Lonn E. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.. Am Heart J 2007; 154(3):448-53.
Lemieux I, Poirier P, Bergeron J, Almeras N, Lamarche B, Cantin B, Dagenais GR, Després JP. Hypertriglyceridemic waist: A useful screeing phenotype in preventive cardiology?. Can J Cardiol 2007; 23(0):23-31B.
Aboa-Éboulé C, Brisson C, Maunsell, E, Mâsse B, Bourbonnais R, Vézina M, Milot A, Théroux P, Dagenais GR. Job strain and risk of acute recurrent coronary heart disease events in a six-year prospective study.. JAMA 2007; 298(14):1652-60.
Dagenais GR, Gerstein H, Yusuf S, Riddle MC, Ryden L, Bosch J; Origin Trial Investigators. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial.. Am Heart J 2008; 155(1):26-32.
Dagenais GR, Philippon F, Després JP, Dumesnil JG, Cartier P, Bogaty P, Lemieux M, Moisan A. The Quebec Heart Institute : 50 years of excellence in cardiology.. Can J Cardiol 2007; 23(0):5-8B.
Dagenais GR. From HOPE to DREAM and expectations from ONTARGET and TRANSCDEND trials.. J Cardiovasc Med 2008; 4(0):6-9.
Dagenais GR, St-Pierre A, Gilbert P, Lamarche B, Després JP, Bernard PM, Bogaty P. Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease.. CMAJ 2009; 180(1):40-7.
Loon E, Gerstein H, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais GR.. Effect of Ramipril and of Rosiglitazone on carotid intima-media thickness in people with impared glucose tolerance or impaired fasting glucose.. J Am Coll Cardiol 2009; 53(22):2028-35.
Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Roux R, D'Astous M, Bertrand F, Dagenais GR, Brophy J. Clinical utility of C-reactive protein measured at admission, hospital discharge or one month later to predict outcome in patients with accute coronary disease: The RISCA study.. J Am Coll Cardiol 2008; 51(24):2339-46.
Bogaty P, Poirier P, Boyer L, Simard S, Morin J, Dagenais GR.. Effects of exogenous metabolic substrate modulation on exercise-induced myocardial ischemia. Am Heart J 2008; 156(4):790-6.
Held C, Sumner G, Sheridan P, McQueen M, Smith S, Dagenais G, Yusuf S, Lonn E. Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).. Vasc Med 2008; 13(4):245-53.
Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.. Lancet 2008; 372(9644):1174-83.
Bakris G, Böhm M, Dagenais G, Diener HC, Fujita T, Gorelick P, Kjeldsen SE, Laakso M, Mancia G, Pitt B, Sharma A, Sleight P, Teo K, Unger T, Weber M, Williams B, Zannad F. Cardiovascular protection for all individuals at high risk: evidence-based best practice.. Clin Res Cardiol 2008; 97(10):713-25.
Makrides L, Dagenais GR, Chockalingam A, LeLorier J, Kishchuk N, Richard J, Stewart J, Chin C, Alloul K, Veinot P. Evaluation of a workplace health program to reduce coronary risk factors.. CGIJ 2008; 13(0):95-105.
Dagenais GR-Bypass Angioplasty Revascularization Investigation 2 Diabetes Study (Member of the Steering Committee. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.. Am Heart J 2008; 156(0):528-36.
Bogaty P, Simard S, Dagenais GR, Brophy JM. Acute coronary syndrome: to CRP or not to CRP ?. J Am Coll Cardiol (letter to the editor) 2008; 52(0):1500-01.
St-Pierre A, Cantin B, Lamarche B, Auger D, Després JP, Dagenais GR. Intermittent claudication: From its risk factors to its long-term prognosis in men. The Quebec Cardiovascular Study.. Can J Cardiol 2010; 26(1):17-21.
Mann JFE, Schmieder RE, Dyal L, McQueen MJ, Schumaker H, Pogue J, Wang X, Probsfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Rydén L, Yu CM, Teo KK, Yusuf S.. Effect of Temisartan on renal outcomes A randomized trial.. Ann Intern Med 2009; 151(1):1-10.
BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE, Dagenais GR.. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease.. N Engl J Med 2009; 360(24):2503-15.
Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Yusoff K, Zatonski W, Rosengren A, Teo KK, Teo KK, Chow CK, Islam S, Zhang M, Xiong J, Dehghan M, Mente A, DeJesus J, Mackie P, Madhavan M, Corsi D, Farago L, Michael J, Kay I, Zafar S, Williams D, Solano R, Solano N, Farago M, Hoard T, Rimac J, Trottier S, ElSheikh W, Hrnic R, Yusuf S, McQueen M, Hall K, Keys J, Wang X, Keneth J, Diaz AR, Orlandini A, Bahit C, Linetsky B, Toscanelli S, Casaccia G, Maini Cuneo JM, Rahman O, Yusuf R, Azad AK, Rabbani KA, Cherry HM, Mannan A, Hassan I, Talukdar AT, Tooheen RB, Khan MU, Avezum A, Oliveira GB, Marcilio CS, Mattos AC, Teo K, Yusuf S, Dejesus J, Zafar S, Williams D, Rimac J, Dagenais G, Poirier P, Turbide G, Auger D, LeBlanc De Bluts A, Proulx MC, Cayer M, Bonneville N, Lear S, Chockalingam A, Gasevic D, Gyawali S, Hage-Moussa S, Mah G, MacLeod M, Vukmirovich I, Wielgosz A, Fodor G, Pipe A, Papadakis S, Moroz I, Muthuri S, Lanas F, Seron P, Martinez S, Lisheng CL, Wei L, Chunming C, Xingyu W, Wenhua Z, Jian B, Xiaohong C, Tao C, Xiaoru C, Qing D, Xinye H, Bo H, Yiling H, Xuan J, Jian L, Juan L, Yishi L, Bing L, Bing R, Yi S, Wei W, Yang W, Jun Y, Tai Y, Yi Z, Liancheng Z, Hongye Z, Xiuwen Z, Manlu Z, Fanghong L, Jianfang W, Yindong L, Yan H, Baoxia G, Xiaoyang L, Jianguo W, Yize X, Shiying Z, Jun L, Xiuzhen T, Liangqing Z, Tianlu L, Peng Z, Changlin D, Dong L, Ning L, Xiaolan M, Yuqing Y, Rensheng L, Rongwen B, Ming C, Minfan F, Aiying H, Jing H, Lihua H, Weiping J, Yunchun J, Yunchun J, Shikuan J, Kehua L, Jiangkang L, Yu L, Zhendong L, Xiaolan M, Yurong M, Qingjie M, Yongzhen M, Deren Q, Shangwen S, Jiwen T, Huijuan W, Ming W, Hua W, Qian W, Buliaishan W, Ruiqi W, Yinsheng W, Mengjun X, Xiaojie X, Wenqiang X, Xu X, Shunyun Y, Shuli Y, Kai Y, Songjian Z, Tingjie Z, Yahong Z, Qiang Z, Yihong Z, Lopez-Jaramillo P, Garcia R, Arguello JF, Duneas R, Silva S, Pradilla LP, Ramirez F, Molina DI, Cure C, Perez M, Hernandez E, Arcos E, Fernandez S, Narvaez C, Paez J, Sotomayor A, Garcia H, Sanchez G, David T, Gomez-Arbelaez D, Rico A, Vaz M, Bharathi AV, Swaminathan S, Mony P, Shankar K, Kurpad AV, Jayachitra KG, Kumar N, Mohan V, Deepa M, Parthiban K, Anitha M, Hemavathy S, Rahulashankiruthiyayan T, Anitha D, Sridevi K, Gupta R, Panwar RB, Mohan I, Rastogi P, Rastogi S, Bhargava R, Kumar R, Thakur JS, Patro B, Mahajan R, Chaudary P, Raman Kutty V, Vijayakumar K, Ajayan K, Rajasree G, Renjini AR, Deepu A, Sandhya B, Asha S, Soumya HS, Kelishadi R, Bahonar A, Mohammadifard N, Heidari H, Yusoff K, Nawawi HM, Ismail TS, Ramli AS, Razali R, Khan NA, Nasir NM, Ahmad R, Winn T, Majid FA, Ismail NH, Hasni MJ, Azmi MT, Zaleha MI, Hazdi KY, Rizam AR, Sazman W, Azman A, Iqbal R, Shahid M, Khawaja R, Kazmi K, Zatonski W, Andrzejak R, Szuba A, Zatonska K, Ilow R, Ferus M, Regulska-Ilow B, Różańska D, Wolyniec M, Kruger A, Voster HH, Schutte AE, Wentzel-Viljoen E, Eloff FC, de Ridder H, Moss H, Potgieter J, Roux AA, Watson M, de Wet G, Olckers A, Jerling JC, Pieters M, Hoekstra T, Puoane T, Igumbor E, Tsolekile L, Sanders D, Naidoo P, Steyn N, Peer N, Mayosi B, Rayner B, Lambert V, Levitt N, Kolbe-Alexander T, Ntyintyane L, Hughes G, Swart R, Fourie J, Muzigaba M, Xapa S, Gobile N, Ndayi K, Jwili B, Ndibaza K, Egbujie B, de Lima T, Petersen M, Govender S, Rosengren A, Bengtsson Boström K, Lindblad U, Langkilde P, Gustavsson A, Andreasson M, Snällman M, Wirdemann L, Pettersson K, Moberg E, Oguz A, Akalin AA, Calik KB, Imeryuz N, Temizhan A, Alphan E, Gunes E, Sur H, Karsidag K, Gulec S, Altuntas Y, Yusufali AM, Almahmeed W, Swidan H, Darwish EA, Hashemi AR, Al-Khaja N, Muscat-Baron JM, Ahmed SH, Mamdouh TM, Darwish WM, Abdelmotagali MH, Omer Awed SA, Movahedi GA, Nusrath F, Al Shaibani H, Gharabou RI, Youssef DF, Nawati AZ, Abu Salah ZA, Abdalla RF, Al Shuwaihi SM, Al Omairi MA, Cadigal OD.. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.. Lancet 2011; 378(9798):1231-43.
Gasevic D, Vukmirovich I, Yusuf S, Teo K, Chow C, Dagenais G, Lear SA. A direct assessment of "obesogenic" built environments: challenges and recommendations.. J Environ Public Health 2011; 2011(0):161574.
The Emerging Risk Factors Collaboration; Investigators/Contributors; Québec Cardiovascular Study: Cantin B, Lamarche B, Després JP, Dagenais GR. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.. Lancet 2010; 375(9709):132-40.
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration; Québec Cardiovascular Study: Cantin B, Lamarche B, Després JP, Dagenais GR. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010; 375(9726):1634-9.
Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J (Cantin B, Després JP, Dagenais GR). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.. Lancet 2010; 375(9733):2215-22.
Noël M, Jobin J, Marcoux A, Poirier P, Dagenais G, Bogaty P. Comparison of myocardial ischemia on the ergocycle versus the treadmill in patients with coronary heart disease.. Am J Cardiol 2010; 105(5):633-9.
Chow CK, Lock K, Madhavan M, Corsi DJ, Gilmore AB, Subramanian SV, Li W, Swaminathan S, Lopez-Jaramillo P, Avezum A, Lear SA, Dagenais G, Teo K, McKee M, Yusuf S. Environmental Profile of a Community's Health (EPOCH): an instrument to measure environmental determinants of cardiovascular health in five countries.. PLoS One 2010; 5(12):e14294.
Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J (Cantin B, Després JP, Dagenais GR). Diabetes mellitus, fasting glucose, and risk of cause-specific death.. N Engl J Med 2011; 364(9):829-41.
ARB Trialists Collaboration, Dagenais GR. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.. J Hypertens 2011; 29(4):623-35.
Aboa-Éboulé C, Brisson C, Maunsell E, Bourbonnais R, Vézina M, Milot A, Dagenais GR. Effort-reward imbalance and recurrent coronary heart disease events : a four-year prospective study of post-myocardial infarction patients.. Psychosom Med 2011; 73(6):436-47.
de Koning L, Gerstein HC, Bosch J, Diaz R, Mohan V, Dagenais G, Yusuf S, Anand SS; EpiDREAM Investigators.. Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetes.. Diabetologia 2010; 53(7):1322-30.
Cairns JA, Yusuf S, Cook RJ, Cox J, Dagenais GR, Devereaux PJ, McAlister FA, McCready T; CANNeCTIN.. Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus.. Can J Cardiol 2010; 26(7):353-8.
Dagenais GR, Lui J, Faxon DP, Kent K, Lago RM, Lezama C, Hueg W, Weiss M, Slater J, Frye RL, and the BARI 2D Study Group.. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.. Circulation 2011; 123(14):1492-500.
Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S; ONTARGET and TRANSCEND Investigators.. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies.. Arch Intern Med 2011; 171(2):142-50.
Aboa-Éboulé C, Brisson C, Maunsell E, Bourbonnais R, Abdous B, Vézina M, Milot A, Dagenais GR. Effort-reward imbalance at work and psychological distress: a validation study of post-myocardial infarction patients.. Psychosom Med 2011; 73(6):448-55.
Anand SS, Dagenais GR, Mohan V, Diaz R, Probstfield J, Freeman R, Shaw J, Lanas F, Avezum A, Budaj A, Jung H, Desai D, Bosch J, Yusuf S, Gerstein HC on behalf of the EpiDREAM Investigators.. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.. Eur J Cardiovasc Prev Rehabil 2012; 19(4):755-64.
Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S; ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators.. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials.. Circulation 2010; 121(12):1439-46.
Verdecchia P, Dagenais G, Healey J, Gao P, Dans AL, Chazova I, Binbrek AS, Iacobellis G, Ferreira R, Holwerda N, Karatzas N, Keltai M, Mancia G, Sleight P, Teo K, Yusuf S, . Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.. J Hypertens 2012; 30(5):1004-1014.
Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield JL, Ramachandran A, Riddle MC, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein HC, Gerstein HC, Yusuf S, Avezum A, Birkeland K, Budaj A, Cardona E, Chaithiraphan S, Chan J, Chazova I, Chen J, Cobitz A, Conget I, Dagenais G, Dans A, Diaz R, Dineen S, Hancu N, Hanefeld M, Heller S, Hildebrandt P, Holman R, Jansky P, Lanas F, Leiter L, Lopez-Jaramillo P, Maggioni A, Malaga G, Masud F, Mellbin L, Metelko Z, Murphy K, Niskanen L, O'Donnell M, Pan CY, Parkhomenko A, Pirags V, Probstfield J, Punthakee Z, Ramachandran A, Raptis S, Raslova K, Raubenheimer P, Riddle M, Ryden L, Stoel I, Tankova T, Yusoff K, Zinman B, Gerstein HC, Yusuf S, Bosch J, Cobitz A, Dagenais G, Diaz R, Holman R, Murphy K, Probstfield J, Punthakee Z, Ramachandran A, Riddle M, Ryden L, Zinman B, Dagenais G, McKelvie R, Anderson N, Pfeffer MA, Bennett PH, Chaturvedi N, DeMets D, McMurray J, Diaz R, Alvarisqueta A, Calella P, Frechtel GD, Ibanez J, Litvak Bruno MR, Lorenzati C, Masjoan F, Medina I, Aizenberg D, Amuchastegui M, Bartolacci I, Bustamante Labarta G, Bustamante Labarta MH, Caccavo A, Cantero MC, Cardona MM, Caruso OE, Cozzi Palma MS, Cuneo C, De la Pertoza SB, Faingold MC, Fernandez R, Fretes JO, Garcia Duran R, Garrido M, Giovanelli J, Gomez Vilamajo O, Grinfeld D, Hrabar A, Iglesias RM, Killinger C, Kuschnir E, Lagrutta M, Lembo LA, Liniado G, Luciardi HL, Luquez HA, Macin S, Maffei L, Marcucci M, Marino J, Massari M, Mociulsky J, Pachetti M, Piskorz D, Rodriguez M, Rodriguez M, Rodriguez Papini N, Romera M, Ronderos R, Sanchez AS, Santos D, Schygiel PO, Selzberg S, Sposetti G, Tirado G, Vico ML, Vogel DR, Wehbe L, Zaidman CJ, Zucchiatti NE, Avezum A, Avezum Oliveira L, Precoma DB, Calsolari Pereira de Souza MR, Cardoso J, Chacra A, Ribeiro de Oliveira R, Abrantes M, Eliaschewitz F, Fernandes Manenti ER, Ferreira dos Santos R, Ferreira Rossi PR, Franco R, Gross JL, Hernandes M, Leo Wajchenberg B, Matos AG, Mendonça Hilgemberg SA, Portes E, Rabelo Alves A Jr, Rassi N, Sgarbi JA, Zanella MT, Tankova T, Zaharieva S, Dagenais G, Leiter L, Abdel-Salam S, Anand S, Aronson R, Belanger A, Berlingieri J, Bhesania T, Cha J, Chiasson J, Goldenberg R, Gottesman I, Gupta G, Hramiak I, Joyce J, Kader T, Kelly A, Liutkus JF, Lochnan H, Lonn E, Magloire P, Mehta P, Milot A, Perron P, Poirier P, Rabasa-Lhoret R, Ransom R, Rioux L, Rizvi Q, Ross S, Saunders K, Sigal R, Sohal PS, St-Hilaire R, Talbot P, Tan K, Ur E, Weisnagel J, Woo W, Lanas F, Aburto M, Acevedo M, Albornoz F, Balboa W, Cobos J, Potthoff S, Saavedra V, Lopez-Jaramillo P, Accini J, Arcos Palma EG, Aroca Martinez G, Botero R, Bruges Ruiz JA, Casanova ME, Garcia L, Garcia Lozada HJ, Hernandez E, Higuera Cobos J, Ibarra Gomez JO, Jaramillo Gomez NI, Luengas CA, Manzur F, Molina DI, Moreno Salgado GA, Orozco A, Perez M, Pertuz Pinzon A, Quintero A, Quiroz R, Sanchez Vallejo G, Sotomayor A, Terront A, Metelko Z, Balen M, Bozikov V, Dubrava D, Erzen D, Goldoni V, Kokić S, Magas S, Maric A, Rubes J, Slosic Weiss S, Sunic E, Tarie D, Tesanovic S, Varzic S, Jansky P, Cech V, Hudcovic M, Jansky P, Jerabek O, Kvapil M, Mandakova E, Oznerova M, Pederzoliova E, Zidkova E, Hildebrandt P, Clemmensen K, Faber J, Helleberg K, Roder M, Svendsen O, Torp-Pedersen C, Urhammer S, Wiggers H, Lopez-Jaramillo P, Duarte Vera Y, Lopez de Felix M, McDermont J, Pasquel Andrade M, Penaherrera E, Niskanen L, Kuusela M, Strand J, Valle T, Hanefeld M, Abdel-Qadar M, Barth D, Bergthold B, Boehm M, Buschmann U, Dietlein M, Donaubauer B, Eckermann T, Elsen A, Forck-Bodeker K, Forst T, Förster A, Frahm E, Frick H, Funke K, Germann H, Grosskopf J, Hagenow A, Hampel T, Hartard M, Himpel A, Huppertz W, Jacob S, Jung T, Klein C, Kleinecke-Pohl U, Kosch C, Krause K, Kusters D, Lahne U, Langenbrink A, Mockesch B, Neuman G, Nischik R, Pohl W, Purr J, Radke R, Regner S, Samer H, Sauter J, Schaefer T, Schaefer A, Schaper F, Schenkenberger I, Schlichthaar H, Schulze E, Schumacher M, Stuchlik G, Tschoepe D, Ulbrich C, Voigt J, Weber H, Weyland K, Wilhelm K, Wilhelm K, Wubbolding H, Zuchner D, Raptis S, Alexandridis T, Boutati E, Elisaf M, Melidonis A, Pappas S, Tentolouris N, Chan J, Lee S, Ozaki R, Tsang CC, Yeung F, Ramachandran A, Aravind S, Babu P, Badgandi M, Bantwal G, Bosco B, Chandratreya S, Chandwani P, Deshmukh V, Deshpande N, Dharmalingam M, Gumpeny S, Iska AK, Jain S, Joseph S, Kale S, Kalra S, Kannampilly J, Kumar H, Kumar PV, Kumar V, Kumar HV, Kumar Sethi B, Muddana A, Murthy S, Nallaperumal S, Pendsey S, Rais N, Ramu Y, Ratnam V, Samad TM, Sawhney JP, Shah P, Shah D, Sharda A, Sharma V, Tandon N, Dinneen S, O'Donnell M, Sreenan S, Maggioni A, Benemio G, Carbonieri E, Corsi A, De Cosmo S, Donatelli F, Fanelli R, Foglini P, Frisinghelli A, Galluzzo A, Giorda C, Lauro D, Lembo G, Metra M, Moretti L, Piatti P, Reboldi G, Pirags V, Andersone I, Eglite A, Jegere B, Konrade I, Lagzdina I, Leitane I, Olte V, Pastare S, Pirags V, Rezgale I, Sokolova J, Stalte V, Stura I, Teterovska D, Vizina B, Yusoff K, Hussein ZB, Mohamed M, Ramanathan L, Tan TB, Cardona E, Alvarado R, Arenas Leon J, Bayram Llamas E, Calvo C, Cardona Muñoz EG, Cervantes Escarcega JL, De la Peña-Toete G, Flota LF, Gonzalez JG, Gonzalez Guerra J, Guerra-Lopez A, Ledesma Velasco M, Lopez Alvarado A, Marquez E, Parcero Valdes J, Pascoe González S, Saldate-Alonso MC, Velasco Sánchez RG, Vidrio-Velazquez M, Violante Ortiz R, Stoel I, Den Hartog FR, Kragten JA, Kuijper A, Lok DJ, Nierop PR, Birkeland K, Istad H, Karlsson T, Langdalen OM, Langslet G, Norheim PD, Risberg K, Sordal T, Traasdahl LF, Masud F, Bilal A, Hashmi ZY, Jabbar A, Raza A, Raza H, Zafar J, Malaga G, Barreda L, Burga J, Garcia F, Goya M, Leon L, Manrique H, Marquina P, Paz-Ibarra JL, Pinto ME, Villena L, Dans A, Edmilao MI, Jimeno C, Morales-Palomares E, Nicodemus N, Paz-Pacheco E, Rogelio G, Roxas-Timonera M, Sevilla R, Sulit DJ, Budaj A, Bronisz M, Czerski T, Franek E, Galaj A, Gniot J, Kopaczewski J, Lysek R, Miekus P, Napora P, Ogorek M, Piepiorka M, Prochaczek F, Racewicz A, Romanczuk P, Szpajer M, Hancu N, Avram RI, Barbonta DH, Candrea EE, Catrinoiu D, Constantinescu S, Dobjanschi CG, Ferariu IE, Ghise G, Mota M, Nafornita V, Nicolau A, Onaca AG, Pintilei E, Pop L, Popa AR, Szilagyi I, Tutescu AC, Veresiu IA, Chazova I, Ageev F, Akhunova S, Ametov A, Ballyuzek M, Barbarash O, Belkov S, Berstein L, Boyarkin M, Boytsov S, Chazova I, Chumakova GA, Dreval A, Ershova O, Esip V, Fitilev S, Galyavich A, Giorgadze M, Goloshchekin B, Gordeev I, Goryachkin I, Ipatko I, Karpov YA, Khasanov N, Kislyak O, Koshelskaya O, Kosmacheva E, Kostenko V, Kostin V, Krivolapova T, Leonova N, Lopatin Y, Lysenko T, Milovanova T, Morozova A, Motylev I, Myasoedova S, Osipova IV, Paltsman Z, Panov A, Reshedko G, Rodionova T, Rodygina E, Samoylova Y, Shestakova M, Shutemova E, Simanenkov V, Simonova G, Stepanovich Yakushin S, Svetlana B, Treshkur TV, Tyurina T, Vorozhtsova I, Zanozina O, Zhukova L, Zykova T, Raslova K, Ilavska A, Navratova D, Nemethyova Z, Ochodnicka Z, Teplanova M, Raubenheimer P, Bhorat A, Blom D, Burgess L, Cassimjee S, Ellis G, Fulat M, Gani M, Hansa S, Kruger S, Latiff G, Madlala T, Mitha E, Mitha I, Moore R, Naidoo D, Ramdass A, Raubenheimer P, Roos JS, Seeber M, Siebert M, van Zyl L, Wing J, Mellbin L, Ryden L, Berndtsson Blom K, Boström PÅ, Herlitz J, Jensen-Agergaard S, Kempe A, Linderfalk C, Liu B, Mathiesen U, Nilsson J, Norrby A, Rosengren A, Svensson KA, Tengmark BO, Torstensson I, Vasko P, Chen J, Chen JH, Cheng JJ, Chiang FT, Chiou HC, Lai WT, Wang JH, Chaithiraphan S, Krittayaphong R, Silaruks S, Sitthisook S, Sritara P, Sukonthasarn A, Parkhomenko A, Lishnevska V, Panina S, Popik G, Saprychova L, Svyshchenko Y, Tseluyko V, Heller S, Ainsworth P, Cruickshank K, Ellerby L, Falk RM, Gaunt R, Hitman G, Khan A, Linton M, Macklin A, O'Kane M, Reed R, Robinson T, Roman M, Rooney D, Shakher J, Silvert B, Taylor N, Webster J, Probstfield J, Riddle M, Ariani M, Barzilay J, Bilazarian S, Bommer W, Brautigam D, Cushman W, Feinglos M, Force R, Giddings S, Gillespie E, Hamaty M, Haywood LJ, Hollander P, Karl D, Kashyap M, Linz P, Nicol P, Nyenwe E, Raghavan V, Solbrig R, Sperl J, Sweeney ME, White J, Wu P, Wyne K, Afzal R, Arsenault J, Bosch J, Burke M, Castelli J, Forbes B, Gerstein HC, Ho L, Joldersma L, Lui S, MacRae L, Marshall T, Ng J, Pogue J, Punthakee Z, Reznick DeMarco Y, Roberts S, Stevens C, Tosta F, Wasala L, Whate A, Yuan F, Yusuf S, Zotova E, Hardman C, Richardson L, White J.. Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.. Diabetologia 2012; 55(1):36-45.
McAlister FA, Marzona I, Dagenais GR, Teo KK, Yusuf S, Jung H, Turnbull F, Neal B, Chalmers J, MacMahon S, Lowering BP, Gerstein H, Marre M, Fox K, Simoons M, Nissen S, Heerspink HL, Brenner B, De Zeeuw D, Pfeffer M, Kober L, Diener HC, Sacco R.. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials.. Eur Heart J 2012; 33(4):505-14.
ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. Basal insulin, cardiovascular and other outcomes in dysglycemia.. N Engl J Med 2012; 367(4):319-28.
ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. Omega 3 fatty acids and cardiovascular outcomes in people with dysglycemia.. N Engl J Med 2012; 367(4):309-18.
Dehghan M, Mente A, Teo KK, Gao P, Sleight P, Dagenais G, Avezum A, Probstfield JL, Dans T, Yusuf S. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries.. Circulation 2012; 126(23):2705-12.
Mohty D, Pibarot P, Echahidi N, Poirier P, Dagenais GR, Dumesnil JG. Reduced systemic arterial compliance measured by routine Doppler echocardiography: a new and independent predictor of mortality in patients with type 2 diabetes mellitus.. Atherosclerosis 2012; 225(2):353-8.
Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J.. C-reactive protein, fibrinogen and cardiovascular disease prediction.. N Engl J Med 2012; 367(0):1310-20.
Dagenais GR, Lu J, Faxon DP, Bogaty P, Adler D, Fuentes F, Escobedo J, Krishnaswami A, Slater J, Frye RL. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.. J Am Coll Cardiol 2013; 61(7):702-11.
Smyth A, Dehghan M, O'Donnell M, Anderson C, Teo K, Gao P, Sleight P, Dagenais G, Probstfield JL, Mente A, Yusuf S. Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries.. Neurology 2015; 84(22):2258-65.
Corsi DJ, Subramanian SV, McKee M, Li W, Swaminathan S, Lopez-Jaramillo P, Avezum A, Lear SA, Dagenais G, Rangarajan S, Teo K, Yusuf S, Chow CK. Environmental Profile of a Community's Health (EPOCH): an ecometric assessment of measures of the community environment based on individual perception.. PLoS One 2012; 7(9):e44410.
Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, Nagel D, Gillum RF, Ford I, Ducimetiere P, Kiechl S, Koenig W, Dullaart RP, Assmann G, D'Agostino RB Sr, Dagenais GR, Cooper JA, Kromhout D, Onat A, Tipping RW, Gómez-de-la-Cámara A, Rosengren A, Sutherland SE, Gallacher J, Fowkes FG, Casiglia E, Hofman A, Salomaa V, Barrett-Connor E, Clarke R, Brunner E, Jukema JW, Simons LA, Sandhu M, Wareham NJ, Khaw KT, Kauhanen J, Salonen JT, Howard WJ, Nordestgaard BG, Wood AM, Thompson SG, Boekholdt SM, Sattar N, Packard C, Gudnason V, Danesh J, Tipping R, Ballantyne C, Hoogeveen R, Virani S, Ndumele C, Nambi V, Willeit J, Willeit P, Mayr A, Santer P, Kiechl S, Gallacher J, Yarnell J, Ben-Shlomo Y, Casiglia E, Tikhonoff V, Sutherland S, Nietert P, Keil J, Bachman D, Psaty B, Cushman M, Tracy R, Jenny N, Nordestgaard B, Tybjærg-Hansen A, Frikke-Schmidt R, Benn M, Kamstrup P, Gómez de la Cámara A, Gutiérrez-Fuentes J, Gómez Gerique J, Rubio Herrera M, Simons L, Friedlander Y, McCallum J, Fowkes FG, Price J, Lee A, Bolton J, Sandhu M, Wareham N, Khaw KT, Harald K, Jousilahti P, Vartiainen E, Salomaa V, D'Agostino R Sr, Wolf P, Vasan R, Benjamin E, Cremer P, Nagel D, Kauhanen J, Salonen J, Nyyssönen K, Tuomainen TP, Koenig W, Meisinger C, Döring A, Mraz W, Rosengren A, Wilhelmsen L, Lappas G, Gillum R, Kwagyan J, Cooper J, Bauer K, Dullaart R, Bakker S, Gansevoort R, van der Harst P, Hillege H, Ducimetiere P, Amouyel P, Arveiler D, Evans A, Ferrières J, Schulte H, Assmann G, Jukema J, Stott D, Westendorp R, Buckley B, Cantin B, Lamarche B, Després JP, Dagenais G, Barrett-Connor E, Wingard D, Daniels L, Gudnason V, Aspelund T, Sigurdsson G, Thorsson B, Eiriksdottir G, Witteman J, Kardys I, Dehghan A, Ikram M, Hofman A, Howard W, Howard B, Zhang Y, Best L, Umans J, Onat A, Can G, Sundström J, Lind L, Giedraitis V, Ingelsson E, Marmot M, Clarke R, Collins R, Fletcher A, Brunner E, Shipley M, Kivimaki M, Ridker P, Buring J, Rifai N, Cook N, Ford I, Robertson M, Feskens E, Geleijnse J, Kromhout D, Walker M, Watson S, Alexander M, Butterworth A, Di Angelantonio E, Franco O, Gao P, Gobin R, Gregson J, Haycock P, Kaptoge S, Pennells L, Saleheen D, Sanderson J, Sarwar N, Thompson A, Thompson S, Walker M, Watson S, Wood A, Wormser D, Zhao X, Danesh J.. Lipid-related markers and cardiovascular disease prediction.. JAMA 2012; 307(23):2499-2506.
Wormser D, Angelantonio ED, Kaptoge S, Wood AM, Gao P, Sun Q, Walldius G, Selmer R, Verschuren WM, Bueno-de-Mesquita HB, Engström G, Ridker PM, Njølstad I, Iso H, Holme I, Giampaoli S, Tunstall-Pedoe H, Gaziano JM, Brunner E, Kee F, Tosetto A, Meisinger C, Brenner H, Ducimetiere P, Whincup PH, Tipping RW, Ford I, Cremer P, Hofman A, Wilhelmsen L, Clarke R, Boer IH, Jukema JW, Ibañez AM, Lawlor DA, D'Agostino RB, Rodriguez B, Casiglia E, Stehouwer CD, Simons LA, Nietert PJ, Barrett-Connor E, Panagiotakos DB, Björkelund C, Strandberg TE, Wassertheil-Smoller S, Blazer DG, Meade TW, Welin L, Svärdsudd K, Woodward M, Nissinen A, Kromhout D, Jørgensen T, Tilvis RS, Guralnik JM, Rosengren A, Taylor JO, Kiechl S, Dagenais GR, Gerry F, Fowkes R, Wallace RB, Khaw KT, Shaffer JA, Visser M, Kauhanen J, Salonen JT, Gallacher J, Ben-Shlomo Y, Kitamura A, Sundström J, Wennberg P, Kiyohara Y, Daimon M, de la Cámara AG, Cooper JA, Onat A, Devereux R, Mukamal KJ, Dankner R, Knuiman MW, Crespo CJ, Gansevoort RT, Goldbourt U, Nordestgaard BG, Shaw JE, Mussolino M, Nakagawa H, Fletcher A, Kuller LH, Gillum RF, Gudnason V, Assmann G, Wald N, Jousilahti PR, Greenland P, Trevisan M, Ulmer H, Butterworth AS, Folsom AR, Davey-Smith G, Hu FB, Danesh J, Tipping RW, Ford CE, Simpson LM, Walldius G, Jungner I, Folsom AR, Demerath EW, Franceschini N, Lutsey PL, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Shaw JE, Atkins R, Zimmet PZ, Barr EL, Knuiman MW, Whincup PH, Wannamethee SG, Morris RW, Willeit J, Kiechl S, Weger S, Oberhollenzer F, Wald N, Ebrahim S, Lawlor DA, Gallacher J, Ben-Shlomo Y, Yarnell JW, Casiglia E, Tikhonoff V, Greenland P, Shay CM, Garside DB, Nietert PJ, Sutherland SE, Bachman DL, Keil JE, de Boer IH, Kizer JR, Psaty BM, Mukamal KJ, Nordestgaard BG, Tybjærg-Hansen A, Jensen GB, Schnohr P, Giampaoli S, Palmieri L, Panico S, Pilotto L, Vanuzzo D, de la Cámara AG, Simons LA, Simons J, McCallum J, Friedlander Y, Gerry F, Fowkes R, Price JF, Lee AJ, Taylor JO, Guralnik JM, Phillips CL, Wallace RB, Kohout FJ, Cornoni-Huntley JC, Guralnik JM, Blazer DG, Guralnik JM, Phillips CL, Phillips CL, Guralnik JM, Khaw KT, Wareham NJ, Brenner H, Schöttker B, Müller H, Rothenbacher D, Wennberg P, Jansson JH, Nissinen A, Donfrancesco C, Giampaoli S, Woodward M, Vartiainen E, Jousilahti PR, Harald K, Salomaa V, D'Agostino RB, Vasan RS, Fox CS, Pencina MJ, Daimon M, Oizumi T, Kayama T, Kato T, Bladbjerg EM, Jørgensen T, Møller L, Jespersen J, Dankner R, Chetrit A, Lubin F, Svärdsudd K, Eriksson H, Welin L, Lappas G, Rosengren A, Lappas G, Welin L, Svärdsudd K, Eriksson H, Lappas G, Bengtsson C, Lissner L, Björkelund C, Cremer P, Nagel D, Strandberg TE, Salomaa V, Tilvis RS, Miettinen TA, Tilvis RS, Strandberg TE, Kiyohara Y, Arima H, Doi Y, Ninomiya T, Rodriguez B, Dekker JM, Nijpels G, Stehouwer CD, Hu FB, Sun Q, Rimm EB, Willett WC, Iso H, Kitamura A, Yamagishi K, Noda H, Goldbourt U, Vartiainen E, Jousilahti PR, Harald K, Salomaa V, Kauhanen J, Salonen JT, Kurl S, Tuomainen TP, Poppelaars JL, Deeg DJ, Visser M, Meade TW, De Stavola BL, Hedblad B, Nilsson P, Engström G, Verschuren WM, Blokstra A, de Boer IH, Shea SJ, Meisinger C, Thorand B, Koenig W, Döring A, Verschuren WM, Blokstra A, Bueno-de-Mesquita HB, Wilhelmsen L, Rosengren A, Lappas G, Fletcher A, Nitsch D, Kuller LH, Grandits G, Tverdal A, Selmer R, Nystad W, Mussolino M, Gillum RF, Hu FB, Sun Q, Manson JE, Rimm EB, Hankinson SE, Meade TW, De Stavola BL, Cooper JA, Bauer KA, Davidson KW, Kirkland S, Shaffer JA, Shimbo D, Kitamura A, Iso H, Sato S, Holme I, Selmer R, Tverdal A, Nystad W, Nakagawa H, Miura K, Sakurai M, Ducimetiere P, Jouven X, Bakker SJ, Gansevoort RT, van der Harst P, Hillege HL, Crespo CJ, Garcia-Palmieri MR, Kee F, Amouyel P, Arveiler D, Ferrières J, Schulte H, Assmann G, Jukema JW, de Craen AJ, Sattar N, Stott DJ, Cantin B, Lamarche B, Després JP, Dagenais GR, Barrett-Connor E, Bergstrom J, Bettencourt RR, Buisson C, Gudnason V, Aspelund T, Sigurdsson G, Thorsson B, Trevisan M, Hofman A, Ikram MA, Tiemeier H, Witteman JC, Tunstall-Pedoe H, Tavendale R, Lowe GD, Woodward M, Devereux R, Yeh JL, Ali T, Calhoun D, Ben-Shlomo Y, Davey-Smith G, Onat A, Can G, Nakagawa H, Sakurai M, Nakamura K, Morikawa Y, Njølstad I, Mathiesen EB, Løchen ML, Wilsgaard T, Sundström J, Ingelsson E, Michaëlsson K, Cederholm T, Gaziano JM, Buring J, Ridker PM, Gaziano JM, Ridker PM, Ulmer H, Diem G, Concin H, Rodeghiero F, Tosetto A, Wassertheil-Smoller S, Manson JE, Marmot M, Clarke R, Fletcher A, Brunner E, Shipley M, Kivimaki M, Ridker PM, Buring J, Ford I, Robertson M, Ibañez AM, Feskens E, Geleijnse JM, Kromhout D, Walker M, Watson S, Alexander M, Butterworth AS, Angelantonio ED, Franco OH, Gao P, Gobin R, Haycock P, Kaptoge S, Seshasai SR, Lewington S, Pennells L, Rapsomaniki E, Sarwar N, Thompson A, Thompson SG, Walker M, Watson S, White IR, Wood AM, Wormser D, Zhao X, Danesh J.. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 2012; 41(5):1419-1433.
Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J, Tipping RW, Folsom AR, Chambless LE, Ballantyne CM, Astor BC, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Atkins R, Barr EL, Shaw JE, Zimmet PZ, Whincup PH, Wannamethee SG, Morris RW, Kiechl S, Willeit J, Mayr A, Schett G, Ebrahim S, Lawlor DA, Yarnell JW, Gallacher J, Cushman M, Psaty BM, Tracy R, Tybjærg-Hansen A, Frikke-Schmidt R, Benn M, Nordestgaard BG, Giampaoli S, Palmieri L, Panico S, Vanuzzo D, Pilotto L, Fowkes FG, Lee AJ, Khaw KT, Wareham NJ, Brenner H, Schöttker B, Müller H, Rothenbacher D, Jansson JH, Wennberg P, Nissinen A, Donfrancesco C, Giampaoli S, Salomaa V, Harald K, Jousilahti P, Vartiainen E, Woodward M, D'Agostino RB Sr, Wolf PA, Benjamin EJ, Pencina MJ, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ, Bladbjerg EM, Jørgensen T, Møller L, Jespersen J, Dankner R, Chetrit A, Lubin F, Wilhelmsen L, Eriksson H, Svärdsudd K, Welin L, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Björkelund C, Lissner L, Bengtsson C, Cremer P, Nagel D, Tilvis RS, Strandberg TE, Kiyohara Y, Arima H, Doi Y, Ninomiya T, Rodriguez B, Dekker JM, Nijpels G, Stehouwer CD, Iso H, Kitamura A, Yamagishi K, Noda H, Kauhanen J, Salonen JT, Deeg D, Bremmer MA, Meade TW, Cooper JA, Hedblad B, Nilsson P, Engström G, Cushman M, Folsom AR, Psaty BM, Shea S, Döring A, Koenig W, Meisinger C, Wilhelmsen L, Rosengren A, Lappas G, Kuller LH, Grandits G, Gillum RF, Mussolino M, Meade TW, Cooper JA, Knottenbelt C, Cooper JA, Bauer KA, Davidson KW, Kirkland S, Shaffer JA, Shimbo D, Kitamura A, Iso H, Sato S, Bakker SJ, Gansevoort RT, Hillege HL, Amouyel P, Arveiler D, Evans A, Ferrières J, Schulte H, Assmann G, Packard CJ, Sattar N, Westendorp RG, Buckley BM, Cantin B, Lamarche B, Després JP, Dagenais GR, Barrett-Connor E, Wingard DL, Bettencourt R, Gudnason V, Aspelund T, Sigurdsson G, Thorsson B, Eiriksdottir G, Witteman J, Kardys I, Dehghan A, Hofman A, Tunstall-Pedoe H, Tavendale R, Lowe GD, Woodward M, Howard BV, Zhang Y, Best L, Umans J, Ben-Shlomo Y, Davey-Smith G, Onat A, Can G, Meade TW, Ingelsson E, Basu S, Cederholm T, Byberg L, Gaziano JM, Stampfer M, Ridker PM, Gaziano JM, Ridker PM, Tosetto A, Rodeghiero F, Wassertheil-Smoller S, Kaplan R, Kooperberg C, Marmot M, Clarke R, Collins R, Fletcher A, Brunner E, Shipley M, Kivimäki M, Ridker PM, Buring J, Cook N, Ford I, Shepherd J, Cobbe SM, Robertson M, Feskens EJ, Kromhout D, Walker M, Watson S, Alexander M, Butterworth AS, Di Angelantonio E, Franco OH, Gao P, Gobin R, Haycock P, Kaptoge S, Kondapally Seshasai SR, Lewington S, Pennells L, Rapsomaniki E, Sarwar N, Thompson A, Thompson SG, Walker M, Watson S, White IR, Wood AM, Wormser D, Zhao X, Danesh J.. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012; 367(14):1310-1320.
Bogaty P, Dagenais GR, Joseph L, Boyer L, Leblanc A, Bélisle P, Brophy JM.. Time variability of C-reactive protein: implications for clinical risk stratification.. PLoS One 2013; 8(4):e60759.
Corsi DJ, Subramanian SV, Chow CK, McKee M, Chifamba J, Dagenais G, Diaz R, Iqbal R, Kelishadi R, Kruger A, Lanas F, López-Jaramilo P, Mony P, Mohan V, Avezum A, Oguz A, Rahman MO, Rosengren A, Szuba A, Li W, Yusoff K, Yusufali A, Rangarajan S, Teo K, Yusuf S.. Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries.. Am Heart J 2013; 166(4):636-46.e4.
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators.. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.. JAMA 2013; 310(9):959-68.
Heerspink HJ, Gao P, Zeeuw DD, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF.. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial.. Eur J Prev Cardiol 2014; 21(3):299-309.
Rodés-Cabau J, Bertrand OF, Larose E, Déry JP, Rinfret S, Urena M, Jerez M, Nombela-Franco L, Ribeiro HB, Allende R, Proulx G, Nguyen CM, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noël B, Côté M, Després JP, Dagenais GR, DeLarochellière R. Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial.. Can J Cardiol 2014; 30(1):138-45.
Teo KK, Pfeffer M, Mancia G, O'Donnell M, Dagenais G, Diaz R, Dans A, Liu L, Bosch J, Joseph P, Copland I, Jung H, Pogue J, Yusuf S. Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial.. Eur Heart J 2014; 35(26):1743-51.
Mente A, O'Donnell MJ, Dagenais G, Wielgosz A, Lear SA, McQueen MJ, Jiang Y, Xingyu W, Jian B, Calik KB, Akalin AA, Mony P, Devanath A, Yusufali AH, Lopez-Jaramillo P, Avezum A Jr, Yusoff K, Rosengren A, Kruger L, Orlandini A, Rangarajan S, Teo K, Yusuf S. Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries.. J Hypertens 2014; 32(5):1005-14; discussio.
Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Chang Yu P, Ryden LE, Pirags V, Spinas GA, Birkeland KI, Ratner RE, Marin-Neto JA, Keltai M, Riddle MC, Bosch J, Yusuf S, Gerstein HC; ORIGIN Trial Investigators.. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia.. Diabetes Care 2014; 37(5):1360-6.
Smith EE, O'Donnell M, Dagenais G, Lear SA, Wielgosz A, Sharma M, Poirier P, Stotts G, Black SE, Strother S, Noseworthy MD, Benavente O, Modi J, Goyal M, Batool S, Sanchez K, Hill V, McCreary CR, Frayne R, Islam S, DeJesus J, Rangarajan S, Teo K, Yusuf S. Early cerebral small vessel disease and brain volume, cognition, and gait.. Ann Neurol 2015; 77(2):251-61.
Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O'Keeffe LM, Gao P, Wood AM, Burgess S, Freitag DF, Pennells L, Peters SA, Hart CL, Håheim LL, Gillum RF, Nordestgaard BG, Psaty BM, Yeap BB, Knuiman MW, Nietert PJ, Kauhanen J, Salonen JT, Kuller LH, Simons LA, van der Schouw YT, Barrett-Connor E, Selmer R, Crespo CJ, Rodriguez B, Verschuren WM, Salomaa V, Svärdsudd K, van der Harst P, Björkelund C, Wilhelmsen L, Wallace RB, Brenner H, Amouyel P, Barr EL, Iso H, Onat A, Trevisan M, D'Agostino RB Sr, Cooper C, Kavousi M, Welin L, Roussel R, Hu FB, Sato S, Davidson KW, Howard BV, Leening MJ, Rosengren A, Dörr M, Deeg DJ, Kiechl S, Stehouwer CD, Nissinen A, Giampaoli S, Donfrancesco C, Kromhout D, Price JF, Peters A, Meade TW, Casiglia E, Lawlor DA, Gallacher J, Nagel D, Franco OH, Assmann G, Dagenais GR, Jukema JW, Sundström J, Woodward M, Brunner EJ, Khaw KT, Wareham NJ, Whitsel EA, Njølstad I, Hedblad B, Wassertheil-Smoller S, Engström G, Rosamond WD, Selvin E, Sattar N, Thompson SG, Danesh J.. Association of cardiometabolic multimorbidity with mortality. JAMA 2015; 314(1):52-60.
Batool S, O'Donnell M, Sharma M, Islam S, Dagenais GR, Poirier P, Lear SA, Wielgosz A, Teo K, Stotts G, McCreary CR, Frayne R, DeJesus J, Rangarajan S, Yusuf S, Smith EE; PURE Study Investigators.. Incidental magnetic resonance diffusion-weighted imaging-positive lesions are rare in neurologically asymptomatic community-dwelling adults.. Stroke 2014; 45(7):2115-7.
Lear SA, Teo K, Gasevic D, Zhang X, Poirier PP, Rangarajan S, Seron P, Kelishadi R, Tamil AM, Kruger A, Iqbal R, Swidan H, Gómez-Arbeláez D, Yusuf R, Chifamba J, Kutty VR, Karsıdag K, Kumar R, Li W, Szuba A, Avezum A, Diaz R, Anand SS, Rosengren A, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study (Collaborateurs: Rangarajan S, Teo KK, Chow CK, Islam S, Zhang M, Kabali C, Dehghan M, Xiong J, Mente A, DeJesus J, Mackie P, Madhavan M, Corsi D, Farago L, Michael J, Kay I, Zafar S, Williams D, Solano R, Solano N, Farago M, Rimac J, Trottier S, ElSheikh W, Mustaha M, Kaszyca J, Hrnic R, Yusuf S, McQueen M, Hall K, Keys J, Wang X, Keneth J, Diaz R, Orlandini A, Bahit C, Linetsky B, Toscanelli S, Casaccia G, Maini Cuneo JM, Rahman O, Yusuf R, Azad AK, Rabbani KA, Cherry HM, Mannan A, Hassan I, Talukdar AT, Tooheen RB, Khan MU, Avezum A, Oliveira GB, Marcilio CS, Mattos AC, Teo K, Yusuf S, Dejesus J, Zafar S, Williams D, Rimac J, Dagenais G, Poirier P, Turbide G, Auger D, LeBlanc De Bluts A, Proulx MC, Cayer M, Bonneville N, Lear S, Chockalingam A, Gasevic D, Gyawali S, Hage-Moussa S, Mah G, MacLeod M, Vukmirovich I, Wielgosz A, Fodor G, Pipe A, Papadakis S, Moroz I, Muthuri S, Lanas F, Seron P, Martinez S, Liu L, Li W, Chen C, Wang X, Zhao W, Bo J, Chang X, Chen T, Chen H, Cheng X, Deng Q, He X, Hu B, Jia X, Li J, Li J, Liu X, Ren B, Sun Y, Wang W, Wang Y, Yang J, Zhai Y, Zhang H, Zhao X, Zhu M, Lu F, Wu J, Li Y, Hou Y, Zhang L, Guo B, Liao X, Zhang S, Bian R, Tian X, Li D, Chen D, Wu J, Xiao Y, Liu T, Zhang P, Dong C, Li N, Ma X, Yang Y, Lei R, Fu M, He J, Liu Y, Xing X, Zhou Q, Lopez-Jaramillo P, Garcia R, Arguello JF, Dueñas R, Silva S, Pradilla LP, Ramirez F, Molina DI, Cure-Cure C, Perez M, Hernandez E, Arcos E, Fernandez S, Narvaez C, Paez J, Sotomayor A, Garcia H, Sanchez G, David T, Gómez-Arbeláez D, Rico A, Vaz M, Bharathi AV, Swaminathan S, Mony P, Shankar K, Kurpad AV, Jayachitra KG, Kumar N, Mohan V, Deepa M, Parthiban K, Anitha M, Hemavathy S, Rahulashankiruthiyayan T, Anitha D, Sridevi K, Gupta R, Panwar RB, Mohan I, Rastogi P, Rastogi S, Bhargava R, Kumar R, Thakur JS, Patro B, Mahajan R, Chaudary P, Raman Kutty V, Vijayakumar K, Ajayan K, Rajasree G, Renjini AR, Deepu A, Sandhya B, Asha S, Soumya HS, Kelishadi R, Bahonar A, Mohammadifard N, Heidari H, Yusoff K, Ng KK, Ariffin F, MIskan M, Mohd Arshad MK, Abdul Razak S, Krishnashwari AD, Abu Bakar N, Majid FA, Noorhassim I, Hasni MJ, Azmi MT, Zaleha MI, Hazdi KY, Rizam AR, Sazman W, Azman A, Iqbal R, Afridi A, Khawaja R, Kazmi K, Zatonski W, Andrzejak R, Szuba A, Zatonska K, Ilow R, Ferus M, Regulska-Ilow B, Różańska D, Wolyniec M, Kruger A, Voster HH, Schutte AE, Wentzel-Viljoen E, Eloff FC, de Ridder H, Moss H, Potgieter J, Roux AA, Watson M, de Wet G, Olckers A, Jerling JC, Pieters M, Hoekstra T, Puoane T, Igumbor E, Tsolekile L, Sanders D, Naidoo P, Steyn N, Peer N, Mayosi B, Rayner B, Lambert V, Levitt N, Kolbe-Alexander T, Ntyintyane L, Hughes G, Swart R, Fourie J, Muzigaba M, Xapa S, Gobile N, Ndayi K, Jwili B, Ndibaza K, Egbujie B, de Lima T, Petersen M, Govender S, Rosengren A, Bengtsson Boström K, Lindblad U, Langkilde P, Gustavsson A, Andreasson M, Snällman M, Wirdemann L, Pettersson K, Moberg E, Oguz A, Akalin AA, Calik KB, Imeryuz N, Temizhan A, Alphan E, Gunes E, Sur H, Karsidag K, Gulec S, Altuntas Y, Yusufali AM, Almahmeed W, Swidan H, Darwish EA, Hashemi AR, Al-Khaja N, Muscat-Baron JM, Ahmed SH, Mamdouh TM, Darwish WM, Abdelmotagali MH, Omer Awed SA, Movahedi GA, Hussain F, Al Shaibani H, Gharabou RI, Youssef DF, Nawati AZ, Abu Salah ZA, Abdalla RF, Al Shuwaihi SM, Al Omairi MA, Cadigal OD, Alejandrino RS, Chifamba J, Gwaunza L, Terera G, Mahachi C, Murambiwa P, Machiweni T, Mapanga R). The association between ownership of common household devices and obesity and diabetes in high, middle and low income countries.. CMAJ 2014; 186(4):258-66.
Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, Morrison H, Li W, Wang X, Di C, Mony P, Devanath A, Rosengren A, Oguz A, Zatonska K, Yusufali AH, Lopez-Jaramillo P, Avezum A, Ismail N, Lanas F, Puoane T, Diaz R, Kelishadi R, Iqbal R, Yusuf R, Chifamba J, Khatib R, Teo K, Yusuf S; PURE Investigators (Collaborateurs: Yusuf S, Rangarajan S, Teo KK, Chow CK, O'Donnell M, Mente A, Leong D, Smyth A, Joseph P, Islam S, Zhang M, Hu W, Wong G, Lee S, Manandhar N, Dehghan M, Royerr M, DeJesus J, Lewis G, Mackie P, Farago L, Kay I, Agapay D, Solano R, Ramacham S, Kandy N, Rimac J, Trottier S, ElSheikh W, Mustaha M, Tongana T, Aoucheva N, Swallow J, Ramezani E, Lindeman J, McQueen M, Hall K, Keys J, Wang X, Keneth J, Devanath A, Diaz R, Orlandini A, Linetsky B, Toscanelli S, Casaccia G, Maini Cuneo JM, Rahman O, Yusuf R, Azad AK, Rabbani KA, Cherry HM, Mannan A, Hassan I, Talukdar AT, Tooheen RB, Khan MU, Sintaha M, Choudhury T, Haque R, Parvin S, Avezum A, Oliveira GB, Marcilio CS, Mattos AC, Teo K, Yusuf S, Dejesus J, Agapay D, Tongana T, Solano R, Kay I, Trottier S, Rimac J, Elsheikh W, Heldman L, Ramezani E, Dagenais G, Poirier P, Turbide G, Auger D, LeBlanc A, LeBlanc De Bluts A, Proulx MC, Cayer M, Bonneville N, Lear S, Gasevic D, Corber E, de Jong V, Vukmirovich I, Wielgosz A, Fodor G, Pipe A, Shane A, Lanas F, Seron P, Martinez S, Valdebenito A, Oliveros M, Wei L, Lisheng L, Chunming C, Xingyu W, Wenhua Z, Hongye Z, Xuan J, Bo H, Yi S, Jian B, Xiuwen Z, Xiaohong C, Tao C, Hui C, Xiaohong C, Qing D, Xiaoru C, Qing D, Xinye H, Bo H, Xuan J, Jian L, Juan L, Xu L, Bing R, Yi S, Wei W, Yang W, Jun Y, Yi Z, Hongye Z, Xiuwen Z, Manlu Z, Fanghong L, Jianfang W, Yindong L, Yan H, Liangqing Z, Baoxia G, Xiaoyang L, Shiying Z, Rongwen B, Xiuzhen T, Dong L, Di C, Jianguo W, Yize X, Tianlu L, Peng Z, Changlin D, Ning L, Xiaolan M, Yuqing Y, Rensheng L, Minfan F, Jing H, Yu L, Xiaojie X, Qiang Z, Lopez-Jaramillo P, Camacho Lopez PA, Garcia R, Jurado LJ, Gómez-Arbelaez D, Arguello JF, Duenas R, Silva S, Pradilla LP, Ramirez F, Molina DI, Cure-Cure C, Perez M, Hernandez E, Arcos E, Fernandez S, Narvaez C, Paez J, Sotomayor A, Garcia H, Sanchez G, David T, Rico A, Mony P, Vaz M, Bharathi AV, Swaminathan S, Shankar K, Kurpad AV, Jayachitra KG, Kumar N, Mohan V, Deepa M, Parthiban K, Anitha M, Hemavathy S, Rahulashankiruthiyayan T, Anitha D, Sridevi K, Gupta R, Panwar RB, Mohan I, Rastogi P, Rastogi S, Bhargava R, Kumar R, Thakur JS, Patro B, Lakshmi PV, Mahajan R, Chaudary P, Raman Kutty V, Vijayakumar K, Ajayan K, Rajasree G, Renjini AR, Deepu A, Sandhya B, Asha S, Soumya HS, Kelishadi R, Bahonar A, Mohammadifard N, Heidari H, Yusoff K, Ismail TS, Ng KK, Devi A, Nasir NM, Yasin MM, Miskan M, Rahman EA, Arsad MK, Ariffin F, Razak SA, Majid FA, Bakar NA, Yacob MY, Zainon N, Salleh R, Ramli MK, Halim NA, Norlizan SR, Ghazali NM, Arshad MN, Razali R, Ali S, Othman HR, Hafar CW, Pit A, Danuri N, Basir F, Zahari SN, Abdullah H, Arippin MA, Zakaria NA, Noorhassim I, Hasni MJ, Azmi MT, Zaleha MI, Hazdi KY, Rizam AR, Sazman W, Azman A, Khatib R, Khammash U, Khatib A, Giacaman R, Husseini A, Iqbal R, Afridi A, Khawaja R, Raza A, Kazmi K, Zatonski W, Szuba A, Zatonska K, Ilow R, Ferus M, Regulska-Ilow B, Rózańska D, Wolyniec M, Kruger A, Voster HH, Schutte AE, Wentzel-Viljoen E, Eloff FC, de Ridder H, Moss H, Potgieter J, Roux AA, Watson M, de Wet G, Olckers A, Jerling JC, Pieters M, Hoekstra T, Puoane T, Igumbor E, Tsolekile L, Sanders D, Naidoo P, Steyn N, Peer N, Mayosi B, Rayner B, Lambert V, Levitt N, Kolbe-Alexander T, Ntyintyane L, Hughes G, Swart R, Fourie J, Muzigaba M, Xapa S, Gobile N, Ndayi K, Jwili B, Ndibaza K, Egbujie B, Rosengren A, Bengtsson Bostrom K, Lindblad U, Langkilde P, Gustavsson A, Andreasson M, Snallman M, Wirdemann L, Pettersson K, Moberg E, Oguz A, Akalin AA, Calik KB, Imeryuz N, Temizhan A, Alphan E, Gunes E, Sur H, Karsidag K, Gulec S, Altuntas Y, Yusufali AM, Almahmeed W, Swidan H, Darwish EA, Hashemi AR, Al-Khaja N, Muscat-Baron JM, Ahmed SH, Mamdouh TM, Darwish WM, Abdelmotagali MH, Omer Awed SA, Movahedi GA, Hussain F, Al Shaibani H, Gharabou RI, Youssef DF, Nawati AZ, Abu Salah ZA, Abdalla RF, Al Shuwaihi SM, Al Omairi MA, Cadigal OD, Alejandrino RS, Chifamba J, Gwaunza L, Terera G, Mahachi C, Mrambiwa P, Machiweni T, Mapanga R). Association of urinary sodium and potassium excretion with blood pressure.. N Engl J Med 2014; 371(7):601-11.
Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Iqbal R, Rahman O, Rosengren A, Yusufali A, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Oguz A, McQueen M, McKee M, Dagenais G; PURE Investigators (Collaborateurs: Yusuf S, Rangarajan S, Teo KK, Chow CK, O'Donnell M, Mente A, Leong D, Smyth A, Joseph P, Islam S, Zhang M, Hu W, Wong G, Manandhar N, Dehghan M, Royerr M, DeJesus J, Lewis G, Mackie P, Farago L, Kay I, Agapay D, Solano R, Ramacham S, Kandy N, Rimac J, Trottier S, ElSheikh W, Mustaha M, Tongana T, Aoucheva N, Swallow J, Ramezani E, Lindeman J, McQueen M, Hall K, Keys J, Wang X, Keneth J, Devanath A, Diaz R, Orlandini A, Linetsky B, Toscanelli S, Casaccia G, Cuneo JM, Rahman O, Yusuf R, Azad AK, Rabbani KA, Cherry HM, Mannan A, Hassan I, Talukdar AT, Tooheen RB, Khan MU, Sintaha M, Choudhury T, Haque R, Parvin S, Avezum A, Oliveira GB, Marcilio CS, Mattos AC, Teo K, Yusuf S, Dejesus J, Agapay D, Tongana T, Solano R, Kay I, Trottier S, Rimac J, Elsheikh W, Heldman L, Ramezani E, Dagenais G, Poirier P, Turbide G, Auger D, De Bluts AL, Proulx MC, Cayer M, Bonneville N, Lear S, Gasevic D, Corber E, de Jong V, Vukmirovich I, Wielgosz A, Fodor G, Pipe A, Shane A, Lanas F, Seron P, Martinez S, Valdebenito A, Oliveros M, Li W, Liu L, Chen C, Wang X, Zhao W, Zhang H, JiaXuan, Hu B, Sun Y, Bo J, Zhao X, Chang X, Chen T, Chen H, Chang X, Deng Q, Cheng X, Deng Q, He X, Hu B, JiaXuan, Li J, Li J, Liu X, Ren B, Sun Y, Wang W, Wang Y, Yang J, Zhai Y, Zhang H, Zhao X, Zhu M, Lu F, Wu J, Li Y, Hou Y, Zhang L, Guo B, Liao X, Zhang S, BianRongwen, TianXiuzhen, Li D, Chen D, Wu J, Xiao Y, Liu T, Zhang P, Dong C, Li N, Ma X, Yang Y, Lei R, Fu M, He J, Liu Y, Xing X, Zhou Q, Lopez-Jaramillo P, Lopez PA, Garcia R, Jurado LJ, Gómez-Arbeláez D, Arguello JF, Dueñas R, Silva S, Pradilla LP, Ramirez F, Molina DI, Cure-Cure C, Perez M, Hernandez E, Arcos E, Fernandez S, Narvaez C, Paez J, Sotomayor A, Garcia H, Sanchez G, David T, Rico A, Mony P, Vaz M, Bharathi AV, Swaminathan S, Shankar K, Kurpad AV, Jayachitra KG, Kumar N, Hospital HA, Mohan V, Deepa M, Parthiban K, Anitha M, Hemavathy S, Rahulashankiruthiyayan T, Anitha D, Sridevi K, Gupta R, Panwar RB, Mohan I, Rastogi P, Rastogi S, Bhargava R, Kumar R, Thakur JS, Patro B, Lakshmi PV, Mahajan R, Chaudary P, Kutty VR, Vijayakumar K, Ajayan K, Rajasree G, Renjini AR, Deepu A, Sandhya B, Asha S, Soumya HS, Kelishadi R, Bahonar A, Mohammadifard N, Heidari H, Yusoff K, Ismail TS, Ng KK, Devi A, Nasir NM, Yasin MM, Miskan M, Rahman EA, Arsad MK, Ariffin F, Razak SA, Majid FA, Bakar NA, Yacob MY, Zainon N, Salleh R, Ramli MK, Halim NA, Norlizan SR, Ghazali NM, Arshad MN, Razali R, Ali S, Othman HR, Hafar CW, Pit A, Danuri N, Basir F, Zahari SN, Abdullah H, Arippin MA, Zakaria NA, Noorhassim I, Hasni MJ, Azmi MT, Zaleha MI, Hazdi KY, Rizam AR, Sazman W, Azman A, Khatib R, Khammash U, Giacaman R, Husseini A, Abu-Diab K, Warrad M, Iqbal R, Afridi A, Khawaja R, Raza A, Kazmi K, Zatonski W, Szuba A, Zatonska K, Ilow R, Ferus M, Regulska-Ilow B, Różańska D, Wolyniec M, Kruger A, Voster HH, Schutte AE, Wentzel-Viljoen E, Eloff FC, de Ridder H, Moss H, Potgieter J, Roux AA, Watson M, de Wet G, Olckers A, Jerling JC, Pieters M, Hoekstra T, Puoane T, Igumbor E, Tsolekile L, Sanders D, Naidoo P, Steyn N, Peer N, Mayosi B, Rayner B, Lambert V, Levitt N, Kolbe-Alexander T, Ntyintyane L, Hughes G, Swart R, Fourie J, Muzigaba M, Xapa S, Gobile N, Ndayi K, Jwili B, Ndibaza K, Egbujie B, Rosengren A, Boström KB, Lindblad U, Langkilde P, Gustavsson A, Andreasson M, Snällman M, Wirdemann L, Pettersson K, Moberg E, Oguz A, Akalin AA, Calik KB, Imeryuz N, Temizhan A, Alphan E, Gunes E, Sur H, Karsidag K, Gulec S, Altuntas Y, Yusufali AM, Almahmeed W, Swidan H, Darwish EA, Hashemi AR, Al-Khaja N, Muscat-Baron JM, Ahmed SH, Mamdouh TM, Darwish WM, Abdelmotagali MH, Awed SA, Movahedi GA, Hussain F, Al Shaibani H, Gharabou RI, Youssef DF, Nawati AZ, Abu Salah ZA, Abdalla RF, Al Shuwaihi SM, Al Omairi MA, Cadigal OD, Alejandrino RS, Chifamba J, Gwaunza L, Terera G, Mahachi C, Mrambiwa P, Machiweni T, Mapanga R). Cardiovascular risk and events in 17 low-, middle-, and high-income countries.. N Engl J Med 2014; 371(9):818-27.
Punthakee Z, Alméras N, Després JP, Dagenais GR, Anand SS, Hunt DL, Sharma AM, Jung H, Yusuf S, Gerstein HC. Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial.. Diabet Med 2014; 31(9):1086-92.
Teo KK, Cohen E, Buller C, Hassan A, Carere R, Cox JL, Ly H, Fedak PW, Chan K, Légaré JF, Connelly K, Tanguay JF, Ye J, Gupta M, John Mancini GB, Dagenais G, Williams R, Teoh K, Latter DA, Townley R, Meyer SR. Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization--multivessel coronary artery disease.. Can J Cardiol 2014; 30(12):1482-91.
Chow CK, Corsi DJ, Lock K, Madhavan M, Mackie P, Li W, Yi S, Wang Y, Swaminathan S, Lopez-Jaramillo P, Gomez-Arbelaez D, Avezum Á, Lear SA, Dagenais G, Teo K, McKee M, Yusuf S. A novel method to evaluate the community built environment using photographs--Environmental Profile of a Community Health (EPOCH) photo neighbourhood evaluation tool.. PLoS One 2014; 9(11):e110042.
O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, Yan H, Lee SF, Mony P, Devanath A, Rosengren A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Yusoff K, Iqbal R, Ilow R, Mohammadifard N, Gulec S, Yusufali AH, Kruger L, Yusuf R, Chifamba J, Kabali C, Dagenais G, Lear SA, Teo K, Yusuf S. Urinary sodium and potassium excretion, mortality, and cardiovascular events.. N Engl J Med 2014; 371(7):612-23.
Dagenais GR, Gerstein HC, Zhang X, McQueen M, Lear S, Lopez-Jaramillo P, Mohan V, Mony P, Gupta R, Kutty VR, Kumar R, Rahman O, Yusoff K, Zatonska K, Oguz A, Rosengren A, Kelishadi R, Yusufali A, Diaz R, Avezum A, Lanas F, Kruger A, Peer N, Chifamba J, Iqbal R, Ismail N, Xiulin B, Jiankang L, Wenqing D, Gejie Y, Rangarajan S, Teo K, Yusuf S. Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results from the Prospective Urban and Rural Epidemiology Study.. Diabetes Care 2016; 39(5):780-7.
Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, Wei L, Mony P, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear SA, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Kazmi K, Rahman O, Rosengren A, Monsef N, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Temizhan A, Dagenais G, Gafni A, Yusuf S. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.. Lancet 2016; 387(10013):61-9.
Boudreau F, Walthouwer MJ, de Vries H, Dagenais GR, Turbide G, Bourlaud AS, Moreau M, Côté J, Poirier P. Rationale, design and baseline characteristics of a randomized controlled trial of a web-based computer-tailored physical activity intervention for adults from Quebec City.. BMC Public Health 2015; 15(1):1038.
Smyth A, Teo KK, Rangarajan S, O'Donnell M, Zhang X, Rana P, Leong DP, Dagenais G, Seron P, Rosengren A, Schutte AE, Lopez-Jaramillo P, Oguz A, Chifamba J, Diaz R, Lear S, Avezum A, Kumar R, Mohan V, Szuba A, Wei L, Yang W, Jian B, McKee M, Yusuf S. Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study.. Lancet 2015; 386(10007):1945-54.
Raina P, Sohel N, Oremus M, Shannon H, Mony P, Kumar R, Li W, Wang Y, Wang X, Yusoff K, Yusuf R, Iqbal R, Szuba A, Oguz A, Rosengren A, Kruger A, Chifamba J, Mohammadifard N, Darwish EA, Dagenais G, Diaz R, Avezum A, Lopez-Jaramillo P, Seron P, Rangarajan S, Teo K, Yusuf S. Assessing global risk factors for non-fatal injuries from road traffic accidents and falls in adults aged 35-70?years in 17 countries: a cross-sectional analysis of the Prospective Urban Rural Epidemiological (PURE) study.. Inj Prev 2016; 22(2):92-98.
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, Kunti K, Kim JH, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJ, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S. Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.. Can J Cardiol 2016; 32(3):311-8.
Mente A, Dagenais G, Wielgosz A, Lear SA, McQueen MJ, Zeidler J, Fu L, DeJesus J, Rangarajan S, Bourlaud AS, De Bluts AL, Corber E, de Jong V, Boomgaardt J, Shane A, Jiang Y, de Groh M, O'Donnell MJ, Yusuf S, Teo K. Assessment of Dietary Sodium and Potassium in Canadians Using 24-Hour Urinary Collection.. Can J Cardiol 2016; 32(3):319-26.
Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D, Sliwa K, Dans A, Avezum A, Piegas LS, Keltai K, Keltai M, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Parkhomenko A, Khunti K, Toff WD, Reid CM, Varigos J, Leiter LA, Molina DI, McKelvie R, Pogue J, Wilkinson J, Jung H, Dagenais G, Yusuf S. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.. N Engl J Med 2016; 374(21):2009-20.
Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.. N Engl J Med 2016; 374(21):2021-31.
Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J, Xavier D, Avezum A, Leiter LA, Piegas LS, Parkhomenko A, Keltai M, Keltai K, Sliwa K, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Accini JL, McKelvie R, Pogue J, Jung H, Liu L, Diaz R, Dans A, Dagenais G. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.. N Engl J Med 2016; 374(21):2032-43.
Chow CK, Corsi DJ, Gilmore AB, Kruger A, Igumbor E, Chifamba J, Yang W, Wei L, Iqbal R, Mony P, Gupta R, Vijayakumar K, Mohan V, Kumar R, Rahman O, Yusoff K, Ismail N, Zatonska K, Altuntas Y, Rosengren A, Bahonar A, Yusufali A, Dagenais G, Lear S, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Rangarajan S, Teo K, McKee M, Yusuf S. Tobacco control environment: cross-sectional survey of policy implementation, social unacceptability, knowledge of tobacco health harms and relationship to quit ratio in 17 low-income, middle-income and high-income countries.. BMJ Open 2017; 7(3):e013817.
Mente A, O'Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Li W, Lu Y, Yi S, Rensheng L, Iqbal R, Mony P, Yusuf R, Yusoff K, Szuba A, Oguz A, Rosengren A, Bahonar A, Yusufali A, Schutte AE, Chifamba J, Mann JF, Anand SS, Teo K, Yusuf S. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.. Lancet 2016; 388(10043):465-75.
Palafox B, McKee M, Balabanova D, AlHabib KF, Avezum AJ, Bahonar A, Ismail N, Chifamba J, Chow CK, Corsi DJ, Dagenais GR, Diaz R, Gupta R, Iqbal R, Kaur M, Khatib R, Kruger A, Kruger IM, Lanas F, Lopez-Jaramillo P, Minfan F, Mohan V, Mony PK, Oguz A, Palileo-Villanueva LM, Perel P, Poirier P, Rangarajan S, Rensheng L, Rosengren A, Soman B, Stuckler D, Subramanian SV, Teo K, Tsolekile LP, Wielgosz A, Yaguang P, Yeates K, Yongzhen M, Yusoff K, Yusuf R, Yusufali A, Zato?ska K, Yusuf S. Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries.. Int J Equity Health 2016; 15(1):199.
Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Chang Yu P, Ryden LE, Pirags V, Spinas GA, Birkeland KI, Ratner RE, Marin-Neto JA, Keltai M, Riddle MC, Bosch J, Yusuf S, Gerstein HC, ORIGIN Trial Investigators.. Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE).. Diabetes Care 2016; 39(5):709-16.
Bosch J, Bosch J, Eikelboom JW, Connolly SJ, Cook Bruns N, Lanius V, Yuan F, Misselwitz F, Chen E, Diaz R, Alings M, Lonn EM, Widimsky P, Hori M, Avezum A, Piegas LS, Bhatt DL, Branch KRH, Probstfield JL, Liang Y, Liu L, Zhu J, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Fox KAA, Kakkar A, Parkhomenko AN, Ertl G, Störk S, Keltai K, Keltai M, Ryden L, Dagenais GR, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Ha JW, Tonkin AM, Varigos JD, Lewis BS, Felix C, Yusoff K, Steg PG, Aboyans V, Metsarinne KP, Anand SS, Hart RG, Lamy A, Moayyedi P, Leong DP, Sharma M, Yusuf S.. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. Can J Cardiol 2017; 33(8):1027-35.
Miller V, Mente A, Dehghan M, Rangarajan S, Zhang X, Swaminathan S, Dagenais G, Gupta R, Mohan V, Lear S, Bangdiwala SI, Schutte AE, Wentzel-Viljoen E, Avezum A, Altuntas Y, Yusoff K, Ismail N, Peer N, Chifamba J, Diaz R, Rahman O, Mohammadifard N, Lana F, Zatonska K, Wielgosz A, Yusufali A, Iqbal R, Lopez-Jaramillo P, Khatib R, Rosengren A, Kutty VR, Li W, Liu J, Liu X, Yin L, Teo K, Anand S, Yusuf S. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study.. Lancet 2017; 390(10107):2037-49.
Mente A, Dehghan M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, Lear S, Li W, Chen H, Yi S, Wang Y, Diaz R, Avezum A, Lopez-Jaramillo P, Seron P, Kumar R, Gupta R, Mohan V, Swaminathan S, Kutty R, Zatonska K, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Nasir NM, Ismail N, Oguz A, Rosengren A, Yusufali A, Wentzel-Viljoen E, Puoane T, Chifamba J, Teo K, Anand SS, Yusuf S. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study.. Lancet Diabetes Endocrinol 2017; 5(1):774-87.
Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, Iqbal R, Kumar R, Wentzel-Viljoen E, Rosengren A, Amma LI, Avezum A, Chifamba J, Diaz R, Khatib R, Lear S, Lopez-Jaramillo P, Liu X, Gupta R, Mohammadifard N, Gao N, Oguz A, Ramli AS, Seron P, Sun Y, Szuba A, Tsolekile L, Wielgosz A, Yusuf R, Hussein Yusufali A, Teo KK, Rangarajan S, Dagenais G, Bangdiwala SI, Islam S, Anand SS, Yusuf S. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study.. Lancet 2017; 390(10107):2050-62.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar A, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators.. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.. N Engl J Med 2017; 377(14):1319-30.
Duceppe E, Parlow J, MacDonald P, Lyons K, McMullen M, Srinathan S, Graham M, Tandon V, Styles K, Bessissow A, Sessler DI, Bryson G, Devereaux PJ (collaborateurs: Auer R, Bhandari M, Cheng D, Choi P, Chow B, Dagenais GR, Fafard J, Guyatt G, Harlock J, Hornstein D, Jacka M, Kurz A, Lanthier L, LeManach Y, McAlister F, McFalls E, McGillion M, Mrkobrada M, Patel A, Sheth T, Tiboni M, Wijeysundera D). Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol 2017; 33(1):17-32.
Paige E, Barrett J, Pennells L, Sweeting M, Willeit P, DiAngelantonio E, Gudnason V, Nordestgaard BG, Psaty BM, Goldbourt U, Best LG, Assmann G, Salonen JT, Nietert PJ, Verschuren WMM, Brunner EJ, Kronmal RA, Salomaa V, Bakker SJL, Dagenais GR, Sato S, Jansson JH, Willeit J, Onat A, de la Camara AG, Roussel R, Volzke H, Dankner R, Tipping RW, Meade TW, Donfrancesco C, Kuller LH, Peters A, Galacher J, Kromhout D, Iso H, Knulman M, Casiglia E, Kavousi M, Palmieri L, Sundstrom J, Davis BR, Njolstad I, Couper D, Danesh D, Thompson SG, Wood A.. Use of repeated blood pressure and cholesterol measurements to improve prediction of cardiovascular disease risk: an individual-participant-data meta-analysis.. Am J Epidemiol 2017; 186(8):899-907.
Connolly SJ, Eikelboom JW, Bosch J, Dagenais G, Dyal L, Lanas F, Metsarinne K, O'Donnell M, Dans AL, Ha JW, Parkhomenko AN, Avezum AA, Lonn E, Lisheng L, Torp-Pedersen C, Widimsky P, Maggioni AP, Felix C, Keltai K, Hori M, Yusoff K, Guzik TJ, Bhatt DL, Branch KRH, Cook Bruns N, Berkowitz SD, Anand SS, Varigos JD, Fox KAA, Yusuf S. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.. Lancet 2017; 0(0):Epub.
Attaei MW, Khatib R, McKee M, Lear S, Dagenais G, Igumbor EU, AlHabib KF, Kaur M, Kruger L, Teo K, Lanas F, Yusoff K, Oguz A, Gupta R, Yusufali AM, Bahonar A, Kutty R, Rosengren A, Mohan V, Avezum A, Yusuf R, Szuba A, Rangarajan S, Chow C, Yusuf S. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data.. Lancet Public Health 2017; 2(9):e411-e419.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riddle MC, Rydén L, Xavier D, Atisso CM, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona-Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw J, Sheu WH, Temelkova-Kurktschiev T; REWIND Trial Investigators.. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.. Diabetes Obes Metab 2018; 20(1):42-49.
Murphy A, Palafox B, O'Donnell O, Stuckler D, Perel P, AlHabib KF, Avezum A, Bai X, Chifamba J, Chow CK, Corsi DJ, Dagenais GR, Dans AL, Diaz R, Erbakan AN, Ismail N, Iqbal R, Kelishadi R, Khatib R, Lanas F, Lear SA, Li W, Liu J, Lopez-Jaramillo P, Mohan V, Monsef N, Mony PK, Puoane T, Rangarajan S, Rosengren A, Schutte AE, Sintaha M, Teo KK, Wielgosz A, Yeates K, Yin L, Yusoff K, Zatońska K, Yusuf S, McKee M.. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study.. Lancet Glob Health 2018; 6(3):e292-e301.
Chow CK, Ramasundarahettige C, Hu W, AlHabib KF, Avezum A Jr, Cheng X, Chifamba J, Dagenais G, Dans A, Egbujie BA, Gupta R, Iqbal R, Ismail N, Keskinler MV, Khatib R, Kruger L, Kumar R, Lanas F, Lear S, Lopez-Jaramillo P, McKee M, Mohammadifard N, Mohan V, Mony P, Orlandini A, Rosengren A, Vijayakumar K, Wei L, Yeates K, Yusoff K, Yusuf R, Yusufali A, Zatonska K, Zhou Y, Islam S, Corsi D, Rangarajan S, Teo K, Gerstein HC, Yusuf S. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.. Lancet Diabetes Endocrinol 2018; 6(10):798-808.
Mente A, O'Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, Lear S, Ah STL, Wei L, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Mony P, Szuba A, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Yusoff K, Ismail N, Gulec S, Rosengren A, Yusufali A, Kruger L, Tsolekile LP, Chifamba J, Dans A, Alhabib KF, Yeates K, Teo K, Yusuf S. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.. Lancet 2018; 392(10146):496-506.
Bosch J, O'Donnell M, Swaminathan B, Lonn EM, Sharma M, Dagenais G, Diaz R, Khunti K, Lewis BS, Avezum A, Held C, Keltai M, Reid C, Toff WD, Dans A, Leiter LA, Sliwa K, Lee SF, Pogue JM, Hart R, Yusuf S. Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study.. Neurology 2019; 92(13):e1435-e1446.
Lamy A, Eikelboom J, Sheth T, Connolly S, Bosch J, Fox KAA, Zhu J, Lonn E, Dagenais G, Widimsky P, Branch KRH, Bhatt DL, Zheng Z, Straka Z, Dagenais F, Kong Y, Marsden T, Lee SF, Copland I, Yusuf S. Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.. J Am Coll Cardiol 2019; 73(2):121-130.
Connolly SJ, Eikelboom JW, Bosch J, Dagenais G, Dyal L, Lanas F, Metsarinne K, O'Donnell M, Dans AL, Ha JW, Parkhomenko AN, Avezum AA, Lonn E, Lisheng L, Torp-Pedersen C, Widimsky P, Maggioni AP, Felix C, Keltai K, Hori M, Yusoff K, Guzik TJ, Bhatt DL, Branch KRH, Cook Bruns N, Berkowitz SD, Anand SS, Varigos JD, Fox KAA, Yusuf S. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.. Lancet 2018; 391(10117):205-218.
O'Donnell M, Mente A, Rangarajan S, McQueen MJ, O'Leary N, Yin L, Liu X, Swaminathan S, Khatib R, Rosengren A, Ferguson J, Smyth A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Ismail N, Yusoff K, Dans A, Iqbal R, Szuba A, Mohammadifard N, Oguz A, Yusufali AH, Alhabib KF, Kruger IM, Yusuf R, Chifamba J, Yeates K, Dagenais G, Wielgosz A, Lear SA, Teo K, Yusuf S. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.. BMJ 2019; 364(0):l772.
Dagenais GR, Jung H, Bogaty P, Bosch J, Yusuf S, Gerstein HC. Basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycemia. An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) Trial.. Diabetes Obes Metab 2019; 21(6):1502-1505.
Dagenais GR, Jung H, Lonn E, Bogaty PM, Dehghan M, Held C, Avezum A, Jansky P, Keltai M, Leiter LA, Lopez‐Jaramillo P, Toff WD, Bosch J, Yusuf S.. Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial.. J Am Heart Assoc 2018; 7(15):e008918.
Sharma M, Hart RG, Smith EE, Bosch J, Yuan F, Casanova A, Eikelboom JW, Connolly SJ, Wong G, Diaz R, Lopez-Jaramillo P, Ertl G, Störk S, Dagenais GR, Lonn EM, Ryden L, Tonkin AM, Varigos JD, Bhatt DL, Branch KR, Probstfield JL, Kim JH, Ha JW, O'Donnell M, Vinereanu D, Fox KA, Liang Y, Liu L, Zhu J, Pogosova N, Maggioni AP, Avezum A, Piegas LS, Keltai K, Keltai M, Cook Bruns N, Berkowitz S, Yusuf S.. Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.. Int J Stroke 2019; 14(3):270-281.
Khunti K, Jung H, Dans AL, Held C, Dagenais GR, Yusuf S, Lonn E.. Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients.. Can J Cardiol 2019; 35(5):644-652.
Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, Rahman O, Yusoff K, du Plessis JL, Igumbor EU, Chifamba J, Li W, Lu Y, Zhi F, Yan R, Iqbal R, Ismail N, Zatonska K, Karsidag K, Rosengren A, Bahonar A, Yusufali A, Lamelas PM, Avezum A, Lopez-Jaramillo P, Lanas F, O'Byrne PM, Yusuf S; PURE investigators.. Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study.. Lancet Glob Health 2019; 7(5):e613-e623.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators (Poirier P parmi les 1421 collaborateurs). Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.. Lancet 2019; 394(10193):131-138.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O'Donnell M, McKee M, Dagenais G. Modifiable risk factors, cardiovascular disease, and mortality in 155?722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.. Lancet 2020; 395(10226):795-808.
Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, Burgess S, Willeit P, Bolton T, Moons KGM, van der Schouw YT, Selmer R, Khaw KT, Gudnason V, Assmann G, Amouyel P, Salomaa V, Kivimaki M, Nordestgaard BG, Blaha MJ, Kuller LH, Brenner H, Gillum RF, Meisinger C, Ford I, Knuiman MW, Rosengren A, Lawlor DA, Völzke H, Cooper C, Marín Ibañez A, Casiglia E, Kauhanen J, Cooper JA, Rodriguez B, Sundström J, Barrett-Connor E, Dankner R, Nietert PJ, Davidson KW, Wallace RB, Blazer DG, Björkelund C, Donfrancesco C, Krumholz HM, Nissinen A, Davis BR, Coady S, Whincup PH, Jørgensen T, Ducimetiere P, Trevisan M, Engström G, Crespo CJ, Meade TW, Visser M, Kromhout D, Kiechl S, Daimon M, Price JF, Gómez de la Cámara A, Wouter Jukema J, Lamarche B, Onat A, Simons LA, Kavousi M, Ben-Shlomo Y, Gallacher J, Dekker JM, Arima H, Shara N, Tipping RW, Roussel R, Brunner EJ, Koenig W, Sakurai M, Pavlovic J, Gansevoort RT, Nagel D, Goldbourt U, Barr ELM, Palmieri L, Njølstad I, Sato S, Monique Verschuren WM, Varghese CV, Graham I, Onuma O, Greenland P, Woodward M, Ezzati M, Psaty BM, Sattar N, Jackson R, Ridker PM, Cook NR, D'Agostino RB, Thompson SG, Danesh J, Di Angelantonio E; Emerging Risk Factors Collaboration (Després JP et Dagenais GR parmi les 170 collaborateurs). Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.. Eur Heart J 2019; 40(7):621-631.
Brophy JM, Dagenais GR, Boyer L, Garcia-Labbé D, Bogaty P. Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery Disease.. Can J Cardiol 2019; 35(11):1505-1512.
Murphy A, Palafox B, Walli-Attaei M, Powell-Jackson T, Rangarajan S, Alhabib KF, Avezum AJ, Calik KBT, Chifamba J, Choudhury T, Dagenais G, Dans AL, Gupta R, Iqbal R, Kaur M, Kelishadi R, Khatib R, Kruger IM, Kutty VR, Lear SA, Li W, Lopez-Jaramillo P, Mohan V, Mony PK, Orlandini A, Rosengren A, Rosnah I, Seron P, Teo K, Tse LA, Tsolekile L, Wang Y, Wielgosz A, Yan R, Yeates KE, Yusoff K, Zatonska K, Hanson K, Yusuf S, McKee M. The household economic burden of non-communicable diseases in 18 countries.. BMJ Glob Health 2020; 5(2):e002040.
de Souza RJ, Dehghan M, Mente A, Bangdiwala SI, Ahmed SH, Alhabib KF, Altuntas Y, Basiak-Rasa?a A, Dagenais GR, Diaz R, Amma LI, Kelishadi R, Khatib R, Lear SA, Lopez-Jaramillo P, Mohan V, Poirier P, Rangarajan S, Rosengren A, Ismail R, Swaminathan S, Wentzel-Viljoen E, Yeates K, Yusuf R, Teo KK, Anand SS, Yusuf S. Association of nut intake with risk factors, cardiovascular disease, and mortality in 16 countries from 5 continents: analysis from the Prospective Urban and Rural Epidemiology (PURE) study.. Am J Clin Nutr 2020; 112(1):208-219.
Dagenais GR, Rydén L, Leiter LA, Lakshmanan M, Dyal L, Probstfield JL, Atisso CM, Shaw JE, Conget I, Cushman WC, Lopez-Jaramillo P, Lanas F, Cordona Munoz EG, Pirags V, Pogosova N, Basile J, Sheu WHH, Temelkova-Kurktschiev T, Raubenheimer PJ, Keltai M, Hall S, Pais P, Colhoun HM, Riddle MC, Gerstein HC.. Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.. Cardiovasc Diabetol 2020; 19(1):199.
Ferrannini G, Gerstein H, Colhoun HM, Dagenais GR, Diaz R, Dyal L, Lakshmanan M, Mellbin L, Probstfield J, Riddle MC, Shaw JE, Avezum A, Basile JN, Cushman WC, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Pais P, Pīrāgs V, Pogosova N, Raubenheimer PJ, Sheu WHH, Rydén L.. Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.. Eur Heart J 2021; 42(26):2565-2573.
Sharma M, Hart RG, Smith EE, Bosch J, Eikelboom JW, Connolly SJ, Dyal L, Reeh KW, Casanova A, Diaz R, Lopez-Jaramillo P, Ertl G, Störk S, Dagenais GR, Lonn EM, Ryden L, Tonkin AM, Varigos JD, Bhatt DL, Branch KRH, Probstfield JL, Kim JH, O'Donnell M, Vinereanu D, Fox KAA, Liang Y, Liu L, Zhu J, Pogosova N, Maggioni AP, Avezum A, Piegas LS, Keltai K, Keltai M, Berkowitz SD, Yusuf S.. Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.. Stroke 2020; 51(10):2901-2909.
Dagenais GR, Leong DP, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R, Diaz R, Avezum A, Oliveira GBF, Wielgosz A, Parambath SR, Mony P, Alhabib KF, Temizhan A, Ismail N, Chifamba J, Yeates K, Khatib R, Rahman O, Zatonska K, Kazmi K, Wei L, Zhu J, Rosengren A, Vijayakumar K, Kaur M, Mohan V, Yusufali A, Kelishadi R, Teo KK, Joseph P, Yusuf S.. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study.. Lancet 2020; 395(10226):785-794.
Yusuf S, Joseph P, Dans A, Gao P, Teo K, Xavier D, López-Jaramillo P, Yusoff K, Santoso A, Gamra H, Talukder S, Christou C, Girish P, Yeates K, Xavier F, Dagenais G, Rocha C, McCready T, Tyrwhitt J, Bosch J, Pais P. Polypill with or without Aspirin in Persons without Cardiovascular Disease.. N Engl J Med 2021; 384(3):216-228.
Mohan D, Mente A, Dehghan M, Rangarajan S, O'Donnell M, Hu W, Dagenais G, Wielgosz A, Lear S, Wei L, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Swaminathan S, Kaur M, Vijayakumar K, Mohan V, Gupta R, Szuba A, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Yusoff K, Gulec S, Rosengren A, Yusufali A, Wentzel-Viljoen E, Chifamba J, Dans A, Alhabib KF, Yeates K, Teo K, Gerstein HC, Yusuf S. Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries.. JAMA Intern Med 2021; 181(5):631-649.
Bosch J, Lonn EM, Jung H, Zhu J, Liu L, Lopez-Jaramillo P, Pais P, Xavier D, Diaz R, Dagenais G, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Held C, Peters RJG, Lewis BS, Jansky P, Yusoff K, Khunti K, Toff WD, Reid CM, Varigos J, Joseph P, Leiter LA, Yusuf S. Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.. Eur Heart J 2021; 42(31):2995-3007.
Bajaj HS, Gerstein H, Basile J, Colhoun H, Conget I, Cushman WC, Dagenais GR, Franek E, Hanefeld M, Keltai M, LakshmananM, Lanas F, Leiter LA, Lopes-Jaramillo P, Pirags V, PogosovaN, Probstfield J, Raubenheimer P, Ryden L, Shaw JE, Sheu WHH, Xavier D.. Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial.. Lancet Diabetes Endocrinol 2021; 9(8):484-490.
Dagenais GR, Dyall L, Bosch JJ, Leong DP, Aboyans V, Berkowitz SD, Bhatt DL, Connolly SJ, Fox KAA, Muehlhofer E, Probstfield JL, Widimsky P, Winkelmann BR, Yusuf S, Eikelboom JW.. Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.. Heart 2021; 107(14):1130-1137.
Eikelboom JW, Bhatt DL, Fox KAA, Bosch J, Connilly SJ, Anand SS, Avezum A, Berkowitz SD, Branch KRH, Dagenais GR, Felix C, Guzik TJ, Hart RG, Maggioni AP, Muehlofer E, Sharma M, Shestakovska.. Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.. J Am Coll Cardiol 2021; 78(1):14-23.
Bosch J, Lonn EM, Dagenais GR, Gao P, Lopez-Jaramilo P, Zhu J, Pais P, Avezum A, Sliwa K, Chazova IE, Peters RJG, Held C, Yusoff K, Lewis PS, Toff WD, Khunti K, Reid CM, Leiter LA, Yusuf S, Hart RG.. Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial.. Stroke 2021; 52(8):2494-2501.
Joseph P, Healey JS, Raina P, Connolly SJ, Ibrahim Q, Gupta R, Avezum A, Dans AL, Lopez-Jaramillo P, Yeates K, Teo K, Douma R, Bahonar A, Chifamba J, Lanas F, Dagenais GR, Lear S, Kumar R, Kengne AP, Keskinler M, Mohan V, Mony P, Alhabib KA,Huisman H, Iype T, Zatonska K, Ismail A, Kazmi K, Rosengren A, Rahman, Yusufali A, Wei L, Orlandini A, Shofiqul Islam O, Rangarajan S, Yusuf S, PURE Investigators.. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals.. Cardiovasc Res 2021; 117(6):1523-1531.
Joseph P, Roshandel G, Gao P, Pais P, Lonn E, Xavier D, Avezum A, Zhu J, Liu L, Sliwa K, Gamra H, Bangdiwala S, Teo K, Diaz R, Dans A, Lopez-Jaramillo P, Prabhakaran D, Castellano JM, Fuster V, Rodgers A, Huffman MD, Bosch J, Dagenais GR, Malekzadeh R, Yusuf S, on behalf of the Polypill Trialists Collaboration.. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.. Lancet 2021; 398(10306):1133-1146.
Cukierman-Yaffe T, Gerstein HC, Basile J, Bethel MA, Cardona-Muñoz EG, Conget I, Dagenais G, Franek E, Hall S, Hancu N, Jansky P, Lakshmanan M, Lanas F, Leiter LA, Lopez-Jaramillo P, Pirags V, Pogosova N, Probstfield J, Rao-Melacini P, Ramasundarahettige C, Raubenheimer PJ, Riddle MC, Rydén L, Shaw JE, Sheu WH, Temelkova-Kurktschiev T. Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.. J Clin Endocrinol Metab 2022; 107(8):e3448-e3454.
Raubenheimer PJ, Cushman WC, Avezum A, Basile J, Conget I, Dagenais G, Hoover A, Jansky P, Lanas F, Leiter LA, Lopez-Jaramillo P, Pogosova N, Probstfield J, Rao-Melacini P, Rydén L, Sheu WH, Temelkova-Kurktschiev T, C Gerstein H. Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.. Diabetes Obes Metab 2022; 24(4):704-712.
Yuan F, Bosch J, Eikelboom JW, Dagenais GR, Connolly SJ, Shaminathan B, Renters M, Dyall L, Bangdiwala S.. A hybrid automated event adjudication system for clinical trials.. Clin Trials 2023; 20(2):166-175.
Emerging Risk Factors Collaboration (Dagenais GR parmi les collaborateurs). Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation.. Lancet Diabetes Endocrinol 2023; 11(10):731-742.
Dagenais GR, Pais P, Gao P, Roshandel G, Malekzadeh R, Joseph P, Yusuf S.. Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysis.. Heart 2023; 109(18):1372-1379.
Lavigne-Robichaud M, Trudel, Milot A, Gilbert-Ouimet M, Vézina M, Laurin D, Dionne CE, Pearce N, Dagenais GR, Brisson C.. Psychosocial Stressors at Work and Coronary Heart Disease Risk in Men and Women: 18-Year Prospective Cohort Study of Combined Exposures.. Circ Cardiovasc Qual Outcomes 2023; 16(10):e009700.
Branch KR, Dagenais G, Avezum A, Basile J, Conget I, Cushman WC, Jansky P, Lakshmanan M, Lanas F, Leiter LA, Pais P, Pogsova N, Raubenheimer PJ, Ryden L, Shaw JE, Sheu WHH, Temelkova-Kurktschiev T, BethelA, Gerstein HC, Probstfield JL.. Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.. Eur J Heart Fail 2022; 24(10):1805-1812.
Gerstein HC, Ramasundarahettige C, Avezum A, Basile J, Conget I, Cushman WC, Dagenais GR, Franek E, Lakshmanan M, Lanas F, Leiter LA, Pogosova N, Probstfield J, Raubenheimer PJ, MC Riddle MC, Shaw JE, Sheu WHH, Temelkova-Kurktschiev T. Turfanda I, Xavier D.. A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.. Cardiovasc Diabetol 2022; 21(1):158.
Pakriti G. Bhatt DL, Dagenais GR, Bosch J, Maggioni A, Widimsky P, Leong D, Fox KAA, Yusuf S, Eikelboom JW.. Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events: A Secondary Analysis of the COMPASS Trial.. JAMA Netw Open 2022; 5(11):e2243201.
Eikelboom JW, Bosch1J, Connelly SJ, TyrwittJ, Fox KAA, Muehlhofer E, Neuman C, Bangdiwala SJ, Diaz R, Alings M, Dagenais GR, Leong DP, Lonn EM, Avezum A, Piegas L, Widimsky P, Parkhomenko AN, Bhatt DL, Branch KRH, Probstfield JL, Lopez-Jaramillo P, Rydén L, Pogosova N, Keltai K, Keltai M, Ertl G, StoerkS, Dans AL, Lanas F, Yan Liang Y, Zhu J, Torp-Pedersen C, Maggioni AP,Commerford PG, Guzik TJ, Thomas Vanassche T, Verhamme P, ODonnell M, Tonkin ANM, Varigos JD, Vinerean D, Felix C, Kim JH, Ibraim KS,Lewis BS, Metsarinne KP, Aboyans V, Steg PG, Hori M, Kakkar A, Anand SS, LamyA, Mukul Sharma M, Yusuf S.. Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.. Eur Heart J Cardiovasc Pharmacother 2022; 8(8):786-795.
Joseph P, Pais P, Gao P, Teo K, Xavier D, Lopez-Jaramillo P, Yusoff K, Santoso A, Gamra H, Talukder SH, Christou C, Dagenais G, Tyrwhitt J, Bosch J, Dans A, Yusuf S. Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial.. Nutr Metab Cardiovasc Dis 2023; 33(2):434-440.
Mente A, Dehghan M, Rangarajan S, O'Donnell M, Hu W, Dagenais G, Wielgosz A, A Lear S, Wei L, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Swaminathan S, Kaur M, Vijayakumar K, Mohan V, Gupta R, Szuba A, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Nasir NM, Karsidag K, Rosengren A, Yusufali A, Wentzel-Viljoen E, Chifamba J, Dans A, Alhabib KF, Yeates K, Teo K, Gerstein HC, Yusuf S. Diet, cardiovascular disease, and mortality in 80 countries.. Eur Heart J 2023; 44(28):2560-2579.
Mancini GBJ, Boden WE, Brooks MM, Vlachos H, Chaitman BR, Frye R, Bittner V, Hartigan PM, Dagenais GR.. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.. Atherosclerosis 2018; 277(0):186-194.
WHO CVD Risk Chart Working Group (Dagenais GR parmi les collaborateurs). World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.. Lancet Glob Health 2019; 7(10):e1332-e1345.
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L,Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH,Bhatt DL, Verhamme PB, ODonnell M, Maggioni AP, Lonn EM,Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L,Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH,Bhatt DL, Verhamme PB, ODonnell M, Maggioni AP, Lonn EM,Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E,Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J,Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A,Parkhomenko AN, Ryden L, Pogosova N, Dans A,Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T,Vinereanu D, Tonkin AM, Lewis BS, Felix C, Khalid Yusoff K,Metsarinne K, Fox KAA, Yusuf S, for the COMPASS Investigators.. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.. Gastroenterology 2019; 157(2):403-412.e5.
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L,Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH,Bhatt DL, Verhamme PB, ODonnell M, Maggioni AP, Lonn EM,Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L,Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH,Bhatt DL, Verhamme PB, ODonnell M, Maggioni AP, Lonn EM,Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E,Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG,Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J,Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A,Parkhomenko AN, Ryden L, Pogosova N, Dans A,Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T,Vinereanu D, Tonkin AM, Lewis BS, Felix C, Khalid Yusoff K,Metsarinne K, Fox KAA, Yusuf S.. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.. Gastroenterology 2019; 157(3):682-691.e2.
Eikelboom JW, Bosch JJ, Connolly SJ, Shestakovska O, Dagenais GR, Hart RG, Leong DP, ODonnell M, Fox KAA, Bhatt LD, Cairns JA, Tasto C, Berkowitz SD, Bruns NC, Muehlhofer E, Diaz R, Maggioni AP, Berkowitz SD Bruns NC, Muelhlhofer E, Diaz R, Maggioni AP, Yusuf S.. Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin.. J Am Coll Cardiol 2019; 74(12):1519-1528.
Boudreau F, Dagenais GR, de Vries H, Walthouwer MJL, Côté J, Turbide G, Bourlaud AS, Poirier P. Effectiveness of a web-based computer-tailored intervention promoting physical activity for adults from Quebec City: a randomized controlled trial.. Health Psychol Behav Med 2020; 8(1):601-622.
Massamba B, Talbot D, Milot A, Trudel X,Vezina M, Dionne CE, Mâsse B, Gilbert-Ouimet M, Dagenais G, Pearce N, Brisson C.. Association between psychosocial work-related factors at midlife and arterial stiffness at older age in a prospective cohort of 1736 white-collar workers.. BMJ Open 2023; 13(9):e073649.
Lamy A, Eikelboom J, Tong W, Yuan F, Bangdwala SI, Bosch J, Connolly S, Lonn E, Dagenais GR, Branch KRH, Wang WJ, Bhatt DL, Probstfield J, Ertl G, Störk CS, Steg PG, Aboyand V, Durand-Zaleski I, Ryden L, Yusuf S .. The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective.. Am J Cardiovasc Drugs 2023; 0(0):Epub.

Dr Gilles R. Dagenais

Domaine de recherche

Description des travaux

Prix et distinctions

Publications

Support tomorrow's medicine, now.